Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in Hepatology

Retrieve available abstracts of 648 articles:
HTML format
Text format



Single Articles


    December 2017
  1. PINATO DJ
    Breaking Kuhn's paradigm in advanced hepatocellular carcinoma.
    Hepatology. 2017 Dec 8. doi: 10.1002/hep.29714.
    PubMed     Text format    


  2. ZHANG H, Li X, Yang Y, Zhang Y, et al
    Significance and Mechanism of Androgen Receptor (AR) Overexpression and AR-mTOR Crosstalk in Hepatocellular Carcinoma.
    Hepatology. 2017 Dec 8. doi: 10.1002/hep.29715.
    PubMed     Text format     Abstract available


  3. MASYUK TV, Masyuk AI, LaRusso NF
    Polycystic Liver Disease: The interplay of genes causative for hepatic and renal cystogenesis.
    Hepatology. 2017 Dec 6. doi: 10.1002/hep.29708.
    PubMed     Text format    


  4. VAN DE GRAAF S, Slijepcevic D
    Reply to D Levy - HEPATOLOGY.
    Hepatology. 2017 Dec 6. doi: 10.1002/hep.29709.
    PubMed     Text format    


  5. LEVY D
    The role of mEH, NTCP and OATP in hepatic sodium-dependent bile acid transport.
    Hepatology. 2017 Dec 6. doi: 10.1002/hep.29712.
    PubMed     Text format    


  6. KAKABADZE Z, Kakabadze A, Chakhunashvili D, Karalashvili L, et al
    Decellularized human placenta supports hepatic tissue and allows rescue in acute liver failure.
    Hepatology. 2017 Dec 6. doi: 10.1002/hep.29713.
    PubMed     Text format     Abstract available


  7. LI DK, Ren Y, Fierer DS, Rutledge S, et al
    The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study.
    Hepatology. 2017 Dec 2. doi: 10.1002/hep.29707.
    PubMed     Text format     Abstract available



  8. 2017 Hepatology referees (volumes 65 and 66).
    Hepatology. 2017;66:2096-2101.
    PubMed     Text format    


  9. TOW C, Brown RS Jr, Tafesh ZH, Schwartz RE, et al
    Hepatology Highlights.
    Hepatology. 2017;66:1709-1712.
    PubMed     Text format    


  10. BHANJI RA, Narayanan P, Allen AM, Malhi H, et al
    Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis.
    Hepatology. 2017;66:2055-2065.
    PubMed     Text format     Abstract available


  11. PETTA S, Valenti L, Tuttolomondo A, Dongiovanni P, et al
    Interferon lambda 4 rs368234815 TT>deltaG variant is associated with liver damage in patients with nonalcoholic fatty liver disease.
    Hepatology. 2017;66:1885-1893.
    PubMed     Text format     Abstract available


  12. HU Y, Shin DJ, Pan H, Lin Z, et al
    YAP suppresses gluconeogenic gene expression through PGC1alpha.
    Hepatology. 2017;66:2029-2041.
    PubMed     Text format     Abstract available


  13. LI XF, Chen C, Xiang DM, Qu L, et al
    Chronic inflammation-elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance.
    Hepatology. 2017;66:1934-1951.
    PubMed     Text format     Abstract available


  14. AUGUSTIN S, Pons M, Maurice JB, Bureau C, et al
    Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease.
    Hepatology. 2017;66:1980-1988.
    PubMed     Text format     Abstract available


  15. SORIA A, Lapadula G, Fabbiani M, Gori A, et al
    Lower effectiveness of hepatitis C antiviral treatment in patients with hepatocellular carcinoma: Is active tumor the clue?
    Hepatology. 2017 Dec 1. doi: 10.1002/hep.29700.
    PubMed     Text format    


  16. JI F, Yeo YH, Wei MT, Wei B, et al
    Hepatocellular carcinoma decreases the effectiveness of hepatitis C antiviral treatment: does direct-acting antiviral regimens matter?
    Hepatology. 2017 Dec 1. doi: 10.1002/hep.29701.
    PubMed     Text format    


    November 2017
  17. SINGH AK, Rooge SB, Varshney A, Vasudevan M, et al
    Global micro RNA expression profiling in the liver biopsies of Hepatitis B Virus infected patients suggests specific miRNA signatures for viral persistence and hepatocellular injury.
    Hepatology. 2017 Nov 30. doi: 10.1002/hep.29690.
    PubMed     Text format     Abstract available


  18. CHANG FM, Wang YP, Lu CL
    Reply: Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study.
    Hepatology. 2017 Nov 24. doi: 10.1002/hep.29686.
    PubMed     Text format    


  19. LIN CY
    Statins and risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: Methodological issues.
    Hepatology. 2017 Nov 24. doi: 10.1002/hep.29687.
    PubMed     Text format    


  20. LO GH, Reiberger T
    Peptic ulcer bleeding in cirrhotic patients: Is as bad as variceal bleeding?
    Hepatology. 2017 Nov 23. doi: 10.1002/hep.29680.
    PubMed     Text format     Abstract available


  21. ZHANG J, Zhang Q, Lou Y, Fu Q, et al
    HIF-1alpha/IL-1beta signaling enhances hepatoma epithelial-mesenchymal transition via macrophages in a hypoxic-inflammatory microenvironment.
    Hepatology. 2017 Nov 23. doi: 10.1002/hep.29681.
    PubMed     Text format     Abstract available


  22. PENG JM, Bera R, Chiou CY, Yu MC, et al
    Actin cytoskeleton remodeling drives epithelial-mesenchymal transition for hepatoma invasion and metastasis.
    Hepatology. 2017 Nov 23. doi: 10.1002/hep.29678.
    PubMed     Text format     Abstract available


  23. BORZIO M, Dionigi E, Rossini A, Marignani M, et al
    External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study. (HEP-17-0903).
    Hepatology. 2017 Nov 22. doi: 10.1002/hep.29662.
    PubMed     Text format     Abstract available


  24. GIANNINI EG, Bucci L, Garuti F, Brunacci M, et al
    Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice.
    Hepatology. 2017 Nov 21. doi: 10.1002/hep.29668.
    PubMed     Text format     Abstract available


  25. CAST A, Valanejad L, Wright M, Nguyen P, et al
    C/EBPalpha-dependent pre-neoplastic tumor foci are the origin of hepatocellular carcinoma and aggressive pediatric liver cancer.
    Hepatology. 2017 Nov 21. doi: 10.1002/hep.29677.
    PubMed     Text format     Abstract available


  26. ZHANG XP, Wang K, Chen ZH, Cheng SQ, et al
    Hepatocellular carcinoma with hepatic vein invasion should not be considered as a contraindication for liver resection.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29665.
    PubMed     Text format    


  27. HOOKS KB, Audoux J, Fazli H, Lesjean S, et al
    New insights into diagnosis and therapeutic options for proliferative hepatoblastoma.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29672.
    PubMed     Text format     Abstract available


  28. PEI Y, Chen XP, Zhang W
    Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: more details, more significance.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29666.
    PubMed     Text format    


  29. SIMON TG, King LY, Chong DQ, Nguyen L, et al
    Diabetes, Metabolic Comorbidities and Risk of Hepatocellular Carcinoma: Results from Two Prospective Cohort Studies.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29660.
    PubMed     Text format     Abstract available


  30. PARK H, O'Brien TR, Rehermann B
    The role of genetics in hepatic fibrosis amongst HCV patients.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29659.
    PubMed     Text format    


  31. LIANG Y, Feng Y, Zong M, Wei X, et al
    beta-Catenin Deficiency in Hepatocytes Aggravates Hepatocarcinogenesis Driven by Oncogenic beta-Catenin and MET.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29661.
    PubMed     Text format     Abstract available


  32. CHAUHAN A, Adams DH
    Exercise alters the hepatic immunophenotype to protect against inflammatory liver disease.
    Hepatology. 2017 Nov 16. doi: 10.1002/hep.29657.
    PubMed     Text format    


  33. KAFFE E, Fiorotto R, Pellegrino F, Mariotti V, et al
    beta-catenin and IL-1beta dependent CXCL10 production drives progression of disease in a mouse model of Congenital Hepatic Fibrosis.
    Hepatology. 2017 Nov 15. doi: 10.1002/hep.29652.
    PubMed     Text format     Abstract available


  34. LIU C, Yang Z, Wu J, Zhang L, et al
    lncRNA H19 interacts with polypyrimidine tract-binding protein 1 to reprogram hepatic lipid homeostasis.
    Hepatology. 2017 Nov 15. doi: 10.1002/hep.29654.
    PubMed     Text format     Abstract available


  35. HERMANN A, Wennmann DO, Gromnitza S, Edeling M, et al
    WWC proteins regulate hepatic cell differentiation and tumorigenesis via the Hippo signaling pathway.
    Hepatology. 2017 Nov 8. doi: 10.1002/hep.29647.
    PubMed     Text format     Abstract available


  36. GARCIA-LEZANA T, Raurell I, Bravo M, Torres-Arauz M, et al
    Restoration of A Healthy Intestinal Microbiota Normalizes Portal Hypertension In A Rat Model of Nonalcoholic Steatohepatitis.
    Hepatology. 2017 Nov 7. doi: 10.1002/hep.29646.
    PubMed     Text format     Abstract available


  37. VARSHNEY A, Panda JJ, Singh AK, Yadav N, et al
    Targeted delivery of miR-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma.
    Hepatology. 2017 Nov 6. doi: 10.1002/hep.29643.
    PubMed     Text format     Abstract available


  38. CAUSSY C, Alquiraish MH, Nguyen P, Hernandez C, et al
    Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis.
    Hepatology. 2017 Nov 6. doi: 10.1002/hep.29639.
    PubMed     Text format     Abstract available


  39. FAGGIOLI F, Palagano E, Di Tommaso L, Donadon M, et al
    B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury.
    Hepatology. 2017 Nov 3. doi: 10.1002/hep.29636.
    PubMed     Text format     Abstract available


  40. GUPTA V, Schwartz RE, Shen N, Brown RS Jr, et al
    Hepatology Highlights.
    Hepatology. 2017;66:1367-1369.
    PubMed     Text format    


  41. XIAO G, Zhu S, Xiao X, Yan L, et al
    Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis.
    Hepatology. 2017;66:1486-1501.
    PubMed     Text format     Abstract available


  42. AMATHIEU R, Al-Khafaji A, Sileanu FE, Foldes E, et al
    Significance of oliguria in critically ill patients with chronic liver disease.
    Hepatology. 2017;66:1592-1600.
    PubMed     Text format     Abstract available


  43. FAN Y, Arechederra M, Richelme S, Daian F, et al
    A phosphokinome-based screen uncovers new drug synergies for cancer driven by liver-specific gain of nononcogenic receptor tyrosine kinases.
    Hepatology. 2017;66:1644-1661.
    PubMed     Text format     Abstract available


  44. NAM EJ, Hayashida K, Aquino RS, Couchman JR, et al
    Syndecan-1 limits the progression of liver injury and promotes liver repair in acetaminophen-induced liver injury in mice.
    Hepatology. 2017;66:1601-1615.
    PubMed     Text format     Abstract available


  45. SCHWIMMER JB, Behling C, Angeles JE, Paiz M, et al
    Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease.
    Hepatology. 2017;66:1474-1485.
    PubMed     Text format     Abstract available


  46. LU Y, Jiang Z, Dai H, Miao R, et al
    Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway.
    Hepatology. 2017 Nov 1. doi: 10.1002/hep.29633.
    PubMed     Text format     Abstract available


  47. RAEMAN R, Anania FA
    Therapy for steatohepatitis: Do macrophages hold the clue?
    Hepatology. 2017 Nov 1. doi: 10.1002/hep.29630.
    PubMed     Text format    


  48. CAVIGLIA JM, Yan J, Jang MK, Gwak GY, et al
    MicroRNA-21 and Dicer are Dispensable for Hepatic Stellate Cell Activation and the Development of Liver Fibrosis.
    Hepatology. 2017 Nov 1. doi: 10.1002/hep.29627.
    PubMed     Text format     Abstract available


  49. TAPPER EB, Parikh N, Sengupta N, Mellinger J, et al
    A Risk Score to Predict the Development of Hepatic Encephalopathy in a Population-Based Cohort of Patients with Cirrhosis.
    Hepatology. 2017 Nov 1. doi: 10.1002/hep.29628.
    PubMed     Text format     Abstract available


    October 2017
  50. AOKI S, Cobbold M, Zhu AX, Duda DG, et al
    Can smart nanomedicine deliver effective targeted cytotoxic treatments to hepatocellular carcinomas while reducing the liver damage?
    Hepatology. 2017 Oct 27. doi: 10.1002/hep.29617.
    PubMed     Text format    


  51. WANG S, Yan ZZ, Yang X, An S, et al
    Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver.
    Hepatology. 2017 Oct 27. doi: 10.1002/hep.29616.
    PubMed     Text format     Abstract available


  52. PATEL N, Sheehan-Dare G, Weir J, Verma S, et al
    Cutaneous metastasis as the first presentation of hepatocellular carcinoma.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29615.
    PubMed     Text format    


  53. SHEN Q, Eun JW, Lee K, Kim HS, et al
    BANF1, PLOD3, SF3B4 as Early-stage Cancer Decision Markers and Drivers of Hepatocellular Carcinoma.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29606.
    PubMed     Text format     Abstract available


  54. PRAKTIKNJO M, Book M, Luetkens J, Pohlmann A, et al
    Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29602.
    PubMed     Text format     Abstract available


  55. SHEN F, Li Y, Yang Wang, Sozzi V, et al
    Hepatitis B Virus Sensitivity to Interferon-alpha in Hepatocytes is More Associated with Cellular Interferon Response than with Viral Genotype.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29609.
    PubMed     Text format     Abstract available


  56. KO E, Seo HW, Jung G
    Telomere length and ROS levels are positively associated with a high risk of mortality and recurrence in hepatocellular carcinoma.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29604.
    PubMed     Text format     Abstract available


  57. JANSEN C, Moller P, Meyer C, Kolbe CC, et al
    Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29612.
    PubMed     Text format     Abstract available


  58. PHILIPS CA, Kumar L, Augustine P
    Partial Splenic Artery Embolization for Severe Hepatic Myelopathy in Cirrhosis.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29597.
    PubMed     Text format     Abstract available


  59. SHERMAN M
    Regorafenib for treatment of hepatocellular carcinoma.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29598.
    PubMed     Text format    


  60. MIDDLETON MS, Van Natta ML, Heba ER, Alazraki A, et al
    Diagnostic Accuracy of Magnetic Resonance Imaging Hepatic Proton Density Fat Fraction in Pediatric Nonalcoholic Fatty Liver Disease.
    Hepatology. 2017 Oct 13. doi: 10.1002/hep.29596.
    PubMed     Text format     Abstract available


  61. VON LOEFFELHOLZ C, Birkenfeld AL
    Is mIndy a mediator of energy metabolism reprogramming in hepatocellular carcinoma induced by IL-6/STAT3 signaling?
    Hepatology. 2017 Oct 12. doi: 10.1002/hep.29591.
    PubMed     Text format    


  62. LU L, Yue S, Jiang L, Li C, et al
    Myeloid Notch1 Deficiency Activates RhoA/ROCK Pathway and Aggravates Hepatocellular Damage In Mouse Ischemic Livers.
    Hepatology. 2017 Oct 12. doi: 10.1002/hep.29593.
    PubMed     Text format     Abstract available


  63. TOSKICH B, Patel T
    Radioembolization for hepatocellular carcinoma - the time has come.
    Hepatology. 2017 Oct 12. doi: 10.1002/hep.29590.
    PubMed     Text format    


  64. CHEN Y, Zeng Z, Lu Y
    Is mIndy a mediator of energy metabolism reprogramming in hepatocellular carcinoma induced by IL-6/STAT3 signaling?
    Hepatology. 2017 Oct 12. doi: 10.1002/hep.29592.
    PubMed     Text format    


  65. YANG JD, Mannalithara A, Piscitello AJ, Kisiel JB, et al
    Impact of Surveillance for Hepatocellular Carcinoma on Survival in Patients with Compensated Cirrhosis.
    Hepatology. 2017 Oct 12. doi: 10.1002/hep.29594.
    PubMed     Text format     Abstract available


  66. EHRLICH L, Glaser SS
    Novel beta-catenin/FXR Interaction Regulates Hepatic Bile Acid Metabolism During Cholestasis.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29584.
    PubMed     Text format    


  67. RAMMOHAN A, Reddy MS, Farouk M, Vargese J, et al
    Pembrolizumab for Metastatic Hepatocellular Carcinoma Following Live Donor Liver Transplantation: The Silver Bullet?
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29575.
    PubMed     Text format     Abstract available


  68. SIDHU SS, Sharma BC, Goyal O, Kishore H, et al
    Reply: Terminating an episode of overt hepatic encephalopathy - L - ornithine L-aspartate may have some role.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29571.
    PubMed     Text format    


  69. WANG F, Hongwei T, Li L, Piontek K, et al
    Exosome - miR-335 as a novel therapeutic strategy in hepatocellular carcinoma.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29586.
    PubMed     Text format     Abstract available


  70. ZHAO J, Adams A, Roberts B, O'Neil M, et al
    PRMT1 and JMJD6 dependent arginine methylation regulate HNF4alpha expression and hepatocyte proliferation.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29587.
    PubMed     Text format     Abstract available


  71. RATHI S, Taneja S
    Terminating an episode of overt hepatic encephalopathy- Lornithine L-aspartate may have some role.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29570.
    PubMed     Text format    


  72. MONTANO-LOZA AJ, Mazurak VC, Ebadi M, Meza-Junco J, et al
    Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29578.
    PubMed     Text format     Abstract available


  73. MURPHY AG, Selaru F
    Extracellular vesicles as novel therapeutics in hepatic failure.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29576.
    PubMed     Text format    


  74. MACDONALD S, Andreola F, Bachtiger P, Amoros A, et al
    Cell death markers in cirrhotic patients with acute decompensation.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29581.
    PubMed     Text format     Abstract available


  75. MASYUK AI, Masyuk TV, Lorenzo Pisarello MJ, Ding JF, et al
    Cholangiocyte Autophagy Contributes to Hepatic Cystogenesis in Polycystic Liver Disease and Represents a Potential Therapeutic Target.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29577.
    PubMed     Text format     Abstract available


  76. PRADHAN-SUNDD T, Zhou L, Vats R, Jiang A, et al
    Dual catenin loss in murine liver causes tight junctional deregulation and progressive intrahepatic cholestasis.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29585.
    PubMed     Text format     Abstract available


  77. BARBIER L, Ronot M, Aussilhou B, Cauchy F, et al
    Polycystic liver disease: Hepatic venous outflow obstruction lesions of the non-cystic parenchyma have major consequences.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29582.
    PubMed     Text format     Abstract available


  78. RAEVENS S, Geerts A, Paridaens A, Lefere S, et al
    Placental growth factor inhibition targets pulmonary angiogenesis and represents a novel therapy for hepatopulmonary syndrome in mice.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29579.
    PubMed     Text format     Abstract available


  79. RUSSO N, Brown RS Jr, Schwartz RE, Rosenblatt R, et al
    Hepatology Highlights.
    Hepatology. 2017;66:1013-1015.
    PubMed     Text format    


  80. ALBILLOS A, Zamora J, Martinez J, Arroyo D, et al
    Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis.
    Hepatology. 2017;66:1219-1231.
    PubMed     Text format     Abstract available


  81. SO-ARMAH KA, Lim JK, Lo Re V, Tate JP, et al
    FIB-4 stage of liver fibrosis predicts incident heart failure among HIV-infected and uninfected patients.
    Hepatology. 2017;66:1286-1295.
    PubMed     Text format     Abstract available


  82. KOLACHALA VL, Palle S, Shen M, Feng A, et al
    Loss of L-selectin-guided CD8+ , but not CD4+ , cells protects against ischemia reperfusion injury in a steatotic liver.
    Hepatology. 2017;66:1258-1274.
    PubMed     Text format     Abstract available


  83. BASURAY S, Smagris E, Cohen JC, Hobbs HH, et al
    The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation.
    Hepatology. 2017;66:1111-1124.
    PubMed     Text format     Abstract available


  84. BANGEN JM, Hammerich L, Sonntag R, Baues M, et al
    Targeting CCl4 -induced liver fibrosis by RNA interference-mediated inhibition of cyclin E1 in mice.
    Hepatology. 2017;66:1242-1257.
    PubMed     Text format     Abstract available


    September 2017
  85. KAKAR S, Ferrell LD
    Glutamine synthetase staining and CTTNB1 mutation in hepatocellular adenomas.
    Hepatology. 2017 Sep 29. doi: 10.1002/hep.29567.
    PubMed     Text format    


  86. RIORDAN JD, Feddersen CR, Tschida BR, Jackson P, et al
    Chronic liver injury alters driver mutation profiles in hepatocellular carcinoma.
    Hepatology. 2017 Sep 29. doi: 10.1002/hep.29565.
    PubMed     Text format     Abstract available


  87. REBOUISSOU S, Bioulac-Sage P, Nault JC, Calderaro J, et al
    Reply to << Glutamine synthetase staining and CTNNB1 mutation in hepatocellular adenomas >>.
    Hepatology. 2017 Sep 29. doi: 10.1002/hep.29563.
    PubMed     Text format    


  88. OU-YANG Q, Lin XM, Zhu YJ, Zheng B, et al
    Distinct Role of Nuclear Receptor Corepressor 1 Regulated de novo Fatty Acids Synthesis in Liver Regeneration and Hepatocarcinogenesis.
    Hepatology. 2017 Sep 28. doi: 10.1002/hep.29562.
    PubMed     Text format     Abstract available


  89. TIMCHENKO NA
    Mitochondrial and anabolic pathways in hepatocellular carcinoma.
    Hepatology. 2017 Sep 28. doi: 10.1002/hep.29559.
    PubMed     Text format    


  90. LUO P, Yin P, Hua R, Tan Y, et al
    A large-scale, multi-center serum metabolite biomarkers identification study for the early detection of hepatocellular carcinoma.
    Hepatology. 2017 Sep 28. doi: 10.1002/hep.29561.
    PubMed     Text format     Abstract available


  91. CHTIOUI H
    OATP1B1 and DAA treatment for hepatitis C in patients with hepatocellular carcinoma.
    Hepatology. 2017 Sep 27. doi: 10.1002/hep.29556.
    PubMed     Text format    


  92. SORIA A, Lapadula G, Fabbiani M, Gori A, et al
    Treatment failure with DAA in hepatocellular carcinoma: More than one explanation?
    Hepatology. 2017 Sep 27. doi: 10.1002/hep.29553.
    PubMed     Text format    


  93. KRENKEL O, Puengel T, Govaere O, Abdallah AT, et al
    Therapeutic Inhibition of Inflammatory Monocyte Recruitment Reduces Steatohepatitis and Liver Fibrosis.
    Hepatology. 2017 Sep 21. doi: 10.1002/hep.29544.
    PubMed     Text format     Abstract available


  94. WYLES D, Poordad F, Wang S, Alric L, et al
    Glecaprevir/Pibrentasvir for HCV Genotype 3 Patients with Cirrhosis and/or Prior Treatment Experience: A Partially Randomized Phase III Clinical Trial.
    Hepatology. 2017 Sep 19. doi: 10.1002/hep.29541.
    PubMed     Text format     Abstract available


  95. LEE MH, Huang YH, Chen HY, Khor CS, et al
    Human Leukocyte Antigen Variants and Risk of Hepatocellular Carcinoma Modified by HCV Genotypes: A Genome-wide Association Study.
    Hepatology. 2017 Sep 16. doi: 10.1002/hep.29531.
    PubMed     Text format     Abstract available


  96. LO RE O, Fusilli C, Rappa F, Van Haele M, et al
    Induction of cancer cell stemness by depletion of macrohistone H2A1 in hepatocellular carcinoma.
    Hepatology. 2017 Sep 15. doi: 10.1002/hep.29519.
    PubMed     Text format     Abstract available


  97. CESARI M, Frigo AC, Tonon M, Angeli P, et al
    Cardiovascular predictors of death in patients with cirrhosis.
    Hepatology. 2017 Sep 13. doi: 10.1002/hep.29520.
    PubMed     Text format     Abstract available


  98. WINTERS AC, Tremblay D, Arinsburg S, Mascarenhas J, et al
    Reassessing the Safety Concerns of Utilizing Blood Donations from Patients with Hemochromatosis.
    Hepatology. 2017 Sep 13. doi: 10.1002/hep.29521.
    PubMed     Text format     Abstract available


  99. PISCAGLIA F, Tovoli F, Pini P, Salvatore V, et al
    A new horizon in the prevention of the postembolization syndrome after Transcatheter Arterial Chemioembolization for hepatocellular carcinoma.
    Hepatology. 2017 Sep 13. doi: 10.1002/hep.29517.
    PubMed     Text format    


  100. RIMOLA J, Diaz-Gonzalez A, Darnell A, Varela M, et al
    Complete response under sorafenib in patients with hepatocellular carcinoma. Relationship with dermatologic adverse events.
    Hepatology. 2017 Sep 12. doi: 10.1002/hep.29515.
    PubMed     Text format     Abstract available


  101. WANG B, Fu J, Yu T, Xu A, et al
    Contradictory Effects of Mitochondria- and Non-mitochondria-targeted Antioxidants on Hepatocarcinogenesis by Altering DNA Repair.
    Hepatology. 2017 Sep 12. doi: 10.1002/hep.29518.
    PubMed     Text format     Abstract available


  102. LOOMBA R, Lawitz E, Mantry PS, Jayakumar S, et al
    The ASK1 Inhibitor Selonsertib in Patients with Nonalcoholic Steatohepatitis: A Randomized, Phase 2 Trial.
    Hepatology. 2017 Sep 11. doi: 10.1002/hep.29514.
    PubMed     Text format     Abstract available


  103. LIU CH, Chern GG, Hsu FF, Huang KW, et al
    A multifunctional nanocarrier for efficient TRAIL-based gene therapy against hepatocellular carcinoma with desmoplasia.
    Hepatology. 2017 Sep 8. doi: 10.1002/hep.29513.
    PubMed     Text format     Abstract available


  104. FINN RS, Zhu AX, Wigdan F, Almasri J, et al
    Therapies for Advanced Stage Hepatocellular Carcinoma with Macrovascular invasion or Metastatic Disease: a Systematic Review and Meta-analysis.
    Hepatology. 2017 Sep 7. doi: 10.1002/hep.29486.
    PubMed     Text format     Abstract available


  105. MARSHALL K, Jin J, Atkinson C, Alawieh A, et al
    Natural IgM initiates an inflammatory response important for both hepatic ischemia reperfusion injury and regeneration.
    Hepatology. 2017 Sep 7. doi: 10.1002/hep.29512.
    PubMed     Text format     Abstract available


  106. BORENTAIN P, Colson P, Bolon E, Gauchez P, et al
    Hepatocellular carcinoma complicating hepatitis E virus-related cirrhosis.
    Hepatology. 2017 Sep 5. doi: 10.1002/hep.29508.
    PubMed     Text format    



  107. ERRATUM for Beta-blockers in 2016: Still the safest and most useful drugs for portal hypertension?
    Hepatology. 2017 Sep 4. doi: 10.1002/hep.29171.
    PubMed     Text format    


  108. SCHWARTZ RE, Batisti J, Brown RS Jr, Tafesh Z, et al
    Hepatology Highlights.
    Hepatology. 2017;66:683-685.
    PubMed     Text format    


  109. BOUATTOUR M, Raymond E, Qin S, Cheng AL, et al
    Recent Developments of c-Met as a Therapeutic Target in Hepatocellular Carcinoma.
    Hepatology. 2017 Sep 1. doi: 10.1002/hep.29496.
    PubMed     Text format     Abstract available


  110. TAKYAR V, Nath A, Beri A, Gharib AM, et al
    How healthy are the "Healthy volunteers"? Penetrance of NAFLD in the biomedical research volunteer pool.
    Hepatology. 2017;66:825-833.
    PubMed     Text format     Abstract available


  111. KACHAYLO E, Tschuor C, Calo N, Borgeaud N, et al
    PTEN Down-Regulation Promotes beta-Oxidation to Fuel Hypertrophic Liver Growth After Hepatectomy in Mice.
    Hepatology. 2017;66:908-921.
    PubMed     Text format     Abstract available


  112. PEREA L, Coll M, Sanjurjo L, Blaya D, et al
    Pentraxin-3 modulates lipopolysaccharide-induced inflammatory response and attenuates liver injury.
    Hepatology. 2017;66:953-968.
    PubMed     Text format     Abstract available


  113. SANGRO B, Martinez-Urbistondo D, Bester L, Bilbao JI, et al
    Prevention and treatment of complications of selective internal radiation therapy: Expert guidance and systematic review.
    Hepatology. 2017;66:969-982.
    PubMed     Text format     Abstract available


    August 2017
  114. ROBERTS LR, Sirlin CB, Zaiem F, Almasri J, et al
    Imaging for the Diagnosis of Hepatocellular Carcinoma: a Systematic Review and Meta-analysis.
    Hepatology. 2017 Aug 31. doi: 10.1002/hep.29487.
    PubMed     Text format     Abstract available


  115. KULIK L, Heimbach JK, Zaiem F, Almasri J, et al
    Therapies for Patients with Hepatocellular Carcinoma Awaiting for Liver Transplantation: a Systematic Review and Meta-analysis.
    Hepatology. 2017 Aug 31. doi: 10.1002/hep.29485.
    PubMed     Text format     Abstract available


  116. PICCININ E, Peres C, Bellafante E, Ducheix S, et al
    Hepatic PPARgamma coactivator 1beta drives mitochondrial and anabolic signatures that contribute to hepatocellular carcinoma progression.
    Hepatology. 2017 Aug 31. doi: 10.1002/hep.29484.
    PubMed     Text format     Abstract available


  117. VYAS D, Baptista PM, Brovold M, Moran E, et al
    Self-assembled liver organoids recapitulate hepato-biliary organogenesis in vitro.
    Hepatology. 2017 Aug 23. doi: 10.1002/hep.29483.
    PubMed     Text format     Abstract available


  118. YANG JD, Malhi H
    Green Tea Consumption - A Potential Chemopreventive Measure for Hepatocellular Carcinoma?
    Hepatology. 2017 Aug 21. doi: 10.1002/hep.29481.
    PubMed     Text format    


  119. KABIR TD, Ganda C, Brown RM, Beveridge DJ, et al
    A miR-7/GAS6/TYRO3 axis regulates the growth and invasiveness of sorafenib-resistant cells in human hepatocellular carcinoma.
    Hepatology. 2017 Aug 18. doi: 10.1002/hep.29478.
    PubMed     Text format     Abstract available


  120. RIAZ A, Gabr A, Abouchaleh N, Ali R, et al
    Radioembolization for Hepatocellular Carcinoma: Statistical Confirmation of Improved Survival in Responders by Landmark Analyses.
    Hepatology. 2017 Aug 18. doi: 10.1002/hep.29480.
    PubMed     Text format     Abstract available


  121. WARD ES, Ober RJ
    Hepatic function of FcRn revealed: Implications for overcoming drug-mediated hepatotoxicity.
    Hepatology. 2017 Aug 17. doi: 10.1002/hep.29476.
    PubMed     Text format    


  122. FRIEDMAN SL, Ratziu V, Harrison SA, Abdelmalek MF, et al
    A Randomized, Placebo-Controlled Trial of Cenicriviroc for Treatment of Nonalcoholic Steatohepatitis with Fibrosis.
    Hepatology. 2017 Aug 17. doi: 10.1002/hep.29477.
    PubMed     Text format     Abstract available


  123. PARIKH ND, Marrero WJ, Wang J, Steuer J, et al
    Projected increase in obesity and non-alcoholic steatohepatitis-related liver transplantation waitlist additions in the United States.
    Hepatology. 2017 Aug 17. doi: 10.1002/hep.29473.
    PubMed     Text format     Abstract available


  124. DEMAREZ C, Gerard C, Cordi S, Poncy A, et al
    MiR-337-3p controls hepatobiliary gene expression and transcriptional dynamics during hepatic cell differentiation.
    Hepatology. 2017 Aug 17. doi: 10.1002/hep.29475.
    PubMed     Text format     Abstract available


  125. DE HAAS RJ, Lim C, Bhangui P, Salloum C, et al
    Curative Salvage Liver Transplantation in Cirrhotic patients with Hepatocellular Carcinoma: An intention-to-treat analysis.
    Hepatology. 2017 Aug 14. doi: 10.1002/hep.29468.
    PubMed     Text format     Abstract available


  126. HALGAND B, Desterke C, Riviere L, Fallot G, et al
    Hepatitis B virus pregenomic RNA in hepatocellular carcinoma: A nosological and prognostic determinant.
    Hepatology. 2017 Aug 12. doi: 10.1002/hep.29463.
    PubMed     Text format     Abstract available


  127. LIN YH, Wu MH, Huang YH, Yeh CT, et al
    Taurine upregulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma.
    Hepatology. 2017 Aug 12. doi: 10.1002/hep.29462.
    PubMed     Text format     Abstract available


  128. MATSUDA M, Tsurusaki S, Miyata N, Saijou E, et al
    Oncostatin M causes liver fibrosis by regulating cooperation between hepatic stellate cells and macrophages in mice.
    Hepatology. 2017 Aug 5. doi: 10.1002/hep.29421.
    PubMed     Text format     Abstract available


  129. KRISS M, Burchill M
    HCV and non-hepatic malignancy: Is pre-emptive DAA therapy indicated prior to treatment?
    Hepatology. 2017 Aug 2. doi: 10.1002/hep.29414.
    PubMed     Text format    


  130. SCHNEIDER Y, Brown RS, Saumoy M, Schwartz RE, et al
    Hepatology Highlights - August 2017.
    Hepatology. 2017;66:309-311.
    PubMed     Text format    


  131. STIEDE K, Miao W, Blanchette HS, Beysen C, et al
    Acetyl-coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: A randomized, double-blind, crossover study.
    Hepatology. 2017;66:324-334.
    PubMed     Text format     Abstract available


  132. KOH C, Sakiani S, Surana P, Zhao X, et al
    Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity.
    Hepatology. 2017;66:591-601.
    PubMed     Text format     Abstract available


  133. LAI JC, Covinsky KE, Dodge JL, Boscardin WJ, et al
    Development of a novel frailty index to predict mortality in patients with end-stage liver disease.
    Hepatology. 2017;66:564-574.
    PubMed     Text format     Abstract available


  134. LIU S, Sun Y, Jiang M, Li Y, et al
    Glyceraldehyde-3-phosphate dehydrogenase promotes liver tumorigenesis by modulating phosphoglycerate dehydrogenase.
    Hepatology. 2017;66:631-645.
    PubMed     Text format     Abstract available


  135. HUNT CM, Papay JI, Stanulovic V, Regev A, et al
    Drug rechallenge following drug-induced liver injury.
    Hepatology. 2017;66:646-654.
    PubMed     Text format     Abstract available


  136. SAIKIA P, Bellos D, McMullen MR, Pollard KA, et al
    MicroRNA 181b-3p and its target importin alpha5 regulate toll-like receptor 4 signaling in Kupffer cells and liver injury in mice in response to ethanol.
    Hepatology. 2017;66:602-615.
    PubMed     Text format     Abstract available


    July 2017
  137. GU J, Jeong S, Xia Q
    Intrahepatic cholangiocarcinoma arising from HBV Infection may be a highly selected population for liver transplantation.
    Hepatology. 2017 Jul 31. doi: 10.1002/hep.29413.
    PubMed     Text format    


  138. SIDHU SS, Sharma BC, Goyal O, Kishore H, et al
    L-ornithine L-aspartate in bouts of overt hepatic encephalopathy.
    Hepatology. 2017 Jul 27. doi: 10.1002/hep.29410.
    PubMed     Text format     Abstract available


  139. COBB DA, Golden-Mason L, Rosen HR, Hahn YS, et al
    Hepatocyte-derived exosomes promote T follicular regulatory cell expansion during HCV infection.
    Hepatology. 2017 Jul 27. doi: 10.1002/hep.29409.
    PubMed     Text format     Abstract available


  140. TANDON P, Madsen K, Kao D
    Fecal microbiota transplantation for hepatic encephalopathy - ready for prime time?
    Hepatology. 2017 Jul 22. doi: 10.1002/hep.29396.
    PubMed     Text format    


  141. SAUERBRUCH T
    Continuation of non-selective beta-blockers for patients with liver cirrhosis and hemodynamic non-response?
    Hepatology. 2017 Jul 22. doi: 10.1002/hep.29394.
    PubMed     Text format    


  142. ZHU L, Baker RD, Zhu R, Baker SS, et al
    Sequencing the gut metagenome as a non-invasive diagnosis for advanced nonalcoholic steatohepatitis.
    Hepatology. 2017 Jul 21. doi: 10.1002/hep.29387.
    PubMed     Text format    


  143. LI H, Li X, Liu S, Guo L, et al
    PD-1 Checkpoint Blockade in Combination with an mTOR Inhibitor Restrains Hepatocellular Carcinoma Growth Induced by Hepatoma Cell-Intrinsic PD-1.
    Hepatology. 2017 Jul 21. doi: 10.1002/hep.29360.
    PubMed     Text format     Abstract available


  144. PEDERSEN JS, Kimer N, Henriksen JH, Bendtsen F, et al
    The Royal Free Hospital Cirrhosis Glomerular Filtration Rate: Validation in a Danish Cohort.
    Hepatology. 2017 Jul 20. doi: 10.1002/hep.29386.
    PubMed     Text format    


  145. HIJMANS BS, Boss A, van Dijk TH, Soty M, et al
    Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type Ia.
    Hepatology. 2017 Jul 20. doi: 10.1002/hep.29389.
    PubMed     Text format     Abstract available


  146. KALAFATELI M, Tsochatzis EA
    Reply to "The Royal Free Hospital Cirrhosis Glomerular Filtration Rate: Validation in a Danish Cohort."
    Hepatology. 2017 Jul 20. doi: 10.1002/hep.29391.
    PubMed     Text format    


  147. FU Y, Silverstein S, McCutcheon JN, Dyba M, et al
    An endogenous DNA adduct as a prognostic biomarker for hepatocarcinogenesis and its prevention by Theaphenon E in mice.
    Hepatology. 2017 Jul 18. doi: 10.1002/hep.29380.
    PubMed     Text format     Abstract available


  148. AN S, Zhao LP, Shen LJ, Wang S, et al
    USP18 protects against hepatic steatosis and insulin resistance via its DUB activity.
    Hepatology. 2017 Jul 17. doi: 10.1002/hep.29375.
    PubMed     Text format     Abstract available


  149. MULLISH BH, McDonald JAK, Thursz MR, Marchesi JR, et al
    Correspondence: Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial.
    Hepatology. 2017 Jul 17. doi: 10.1002/hep.29369.
    PubMed     Text format    


  150. ARDEVOL A, Ibanez-Sanz G, Profitos J, Aracil C, et al
    Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapies.
    Hepatology. 2017 Jul 17. doi: 10.1002/hep.29370.
    PubMed     Text format     Abstract available


  151. WU H, Tao J, Li X, Zhang T, et al
    MicroRNA-206 Prevents the Pathogenesis of Hepatocellular Carcinoma Via Modulating Expression of cMet and Cdk6.
    Hepatology. 2017 Jul 17. doi: 10.1002/hep.29374.
    PubMed     Text format     Abstract available


  152. PURI P, Daita K, Joyce A, Mirshahi F, et al
    The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids.
    Hepatology. 2017 Jul 11. doi: 10.1002/hep.29359.
    PubMed     Text format     Abstract available


  153. SARWAR A, Zhou L, Novack V, Tapper EB, et al
    Hospital volume and mortality after trans-jugular intrahepatic portosystemic shunt creation in the United States.
    Hepatology. 2017 Jul 6. doi: 10.1002/hep.29354.
    PubMed     Text format     Abstract available


  154. YANG L, Wang WH, Qiu WL, Guo Z, et al
    A single-cell transcriptomic analysis reveals precise pathways and regulatory mechanisms underlying hepatoblast differentiation.
    Hepatology. 2017 Jul 6. doi: 10.1002/hep.29353.
    PubMed     Text format     Abstract available



  155. Hepatology Highlights.
    Hepatology. 2017;66:1-3.
    PubMed     Text format    


  156. CASSANO M, Offner S, Planet E, Piersigilli A, et al
    Polyphenic trait promotes liver cancer in a model of epigenetic instability in mice.
    Hepatology. 2017;66:235-251.
    PubMed     Text format     Abstract available


  157. PICCOLO P, Annunziata P, Soria LR, Attanasio S, et al
    Down-regulation of hepatocyte nuclear factor-4alpha and defective zonation in livers expressing mutant Z alpha1-antitrypsin.
    Hepatology. 2017;66:124-135.
    PubMed     Text format     Abstract available


  158. UNALP-ARIDA A, Ruhl CE
    Liver fibrosis scores predict liver disease mortality in the United States population.
    Hepatology. 2017;66:84-95.
    PubMed     Text format     Abstract available


  159. MUELLER S, Nahon P, Rausch V, Peccerella T, et al
    Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver disease.
    Hepatology. 2017;66:96-107.
    PubMed     Text format     Abstract available


    June 2017
  160. CHENG X, Xia Y, Serti E, Block PD, et al
    Hepatitis B virus evades innate immunity of hepatocytes but activates macrophages during infection.
    Hepatology. 2017 Jun 30. doi: 10.1002/hep.29348.
    PubMed     Text format     Abstract available


  161. LIU J, Hu X, Chen J, Li X, et al
    Pericentral hepatocytes produce IGF-2 to promote liver regeneration during special injuries.
    Hepatology. 2017 Jun 27. doi: 10.1002/hep.29340.
    PubMed     Text format     Abstract available


  162. LAI Q, Vitale A, Iesari S, Finkenstedt A, et al
    Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer.
    Hepatology. 2017 Jun 27. doi: 10.1002/hep.29342.
    PubMed     Text format     Abstract available


  163. HENRIET E, Hammoud AA, Dupuy JW, Dartigues B, et al
    Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29336.
    PubMed     Text format     Abstract available


  164. TSAI CL, Liu WL, Hsu FM, Yang PS, et al
    Targeting Histone deacetylase 4/Ubc9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29328.
    PubMed     Text format     Abstract available


  165. LIU Y, Zhang Y, Wang S, Dong QZ, et al
    Prospero-related homeobox 1 drives angiogenesis of hepatocellular carcinoma through selectively activating IL-8 expression.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29337.
    PubMed     Text format     Abstract available


  166. DAWSON PA
    Hepatic bile acid uptake in humans and mice: Multiple pathways and expanding potential role for gut-liver signaling.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29325.
    PubMed     Text format    


  167. ZHANG C, Huang J, An W
    Hepatic stimulator substance resists hepatic ischemia-reperfusion injury by regulating Drp1 translocation and activation.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29326.
    PubMed     Text format     Abstract available


  168. YIP LY, Aw CC, Lee SH, Hong YS, et al
    The Liver-Gut Microbiota Axis Modulates Hepatotoxicity of Tacrine in the Rat.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29327.
    PubMed     Text format     Abstract available


  169. KIM DS, Ryu JW, Son MY, Oh JH, et al
    A Liver-specific Gene Expression Panel Predicts the Differentiation Status of in vitro Hepatocyte Models.
    Hepatology. 2017 Jun 22. doi: 10.1002/hep.29324.
    PubMed     Text format     Abstract available


  170. PAPATHEODORIDIS GV, Idilman R, Dalekos GN, Buti M, et al
    The risk of hepatocellular carcinoma is decreasing after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B.
    Hepatology. 2017 Jun 16. doi: 10.1002/hep.29320.
    PubMed     Text format     Abstract available


  171. CHIDA T, Ito M, Nakashima K, Kanegae Y, et al
    Critical role of CREBH-mediated induction of TGF-beta2 by HCV infection in fibrogenic responses in hepatic stellate cells.
    Hepatology. 2017 Jun 16. doi: 10.1002/hep.29319.
    PubMed     Text format     Abstract available


  172. LEE M, Chung GE, Lee JH, Oh S, et al
    Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment.
    Hepatology. 2017 Jun 15. doi: 10.1002/hep.29318.
    PubMed     Text format     Abstract available


  173. GAO Y, Feng J, Yang G, Zhang S, et al
    HBx-elevated MSL2 Modulates HBV cccDNA through Inducing Degradation of APOBEC3B to Enhance Hepatocarcinogenesis.
    Hepatology. 2017 Jun 13. doi: 10.1002/hep.29316.
    PubMed     Text format     Abstract available


  174. TAYLOR EJ, Jones RL, Guthrie JA, Rowe IA, et al
    Modelling the benefits and harms of surveillance for hepatocellular carcinoma: information to support informed choices.
    Hepatology. 2017 Jun 12. doi: 10.1002/hep.29315.
    PubMed     Text format     Abstract available


  175. JIANG L, Yan Q, Fang S, Liu M, et al
    Calcium binding protein 39 promotes hepatocellular carcinoma growth and metastasis by activating ERK signaling pathway.
    Hepatology. 2017 Jun 12. doi: 10.1002/hep.29312.
    PubMed     Text format     Abstract available


  176. BALWANI M, Wang B, Anderson KE, Bloomer JR, et al
    Acute Hepatic Porphyrias: Recommendations for Evaluation and Long Term Management.
    Hepatology. 2017 Jun 12. doi: 10.1002/hep.29313.
    PubMed     Text format     Abstract available


  177. ZHENG C, Zeng H, Lin H, Wang J, et al
    Serum microcystins level positively linked with risk of hepatocellular carcinoma: a case-control study in Southwest China.
    Hepatology. 2017 Jun 9. doi: 10.1002/hep.29310.
    PubMed     Text format     Abstract available


  178. NG CKY, Piscuoglio S, Terracciano LM
    Molecular classification of hepatocellular carcinoma: The view from metabolic zonation.
    Hepatology. 2017 Jun 9. doi: 10.1002/hep.29311.
    PubMed     Text format    


  179. AKINROTIMI O, Riessen R, VanDuyne P, Park JE, et al
    Shp deletion prevents hepatic steatosis and when combined with Fxr loss protects against type 2 diabetes.
    Hepatology. 2017 Jun 6. doi: 10.1002/hep.29305.
    PubMed     Text format     Abstract available


  180. BAJAJ JS, Kassam Z, Fagan A, Gavis EA, et al
    Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial.
    Hepatology. 2017 Jun 6. doi: 10.1002/hep.29306.
    PubMed     Text format     Abstract available


  181. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:1783-1784.
    PubMed     Text format    


  182. DOYCHEVA I, Watt KD, Alkhouri N
    Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic.
    Hepatology. 2017;65:2100-2109.
    PubMed     Text format     Abstract available


  183. AJMERA VH, Terrault NA, Harrison SA
    Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.
    Hepatology. 2017;65:2090-2099.
    PubMed     Text format     Abstract available


    May 2017
  184. MARKWARDT D, Holdt L, Steib C, Benesic A, et al
    Plasma Cystatin C is a predictor of renal dysfunction, ACLF and mortality in patients with acutely decompensated liver cirrhosis.
    Hepatology. 2017 May 25. doi: 10.1002/hep.29290.
    PubMed     Text format     Abstract available


  185. WANG Z, Han J, Zhang H, Wu MC, et al
    Emphasis on Harms of Hepatocellular Carcinoma Surveillance: Just Pretending Innocent After Taking Advantages?
    Hepatology. 2017 May 24. doi: 10.1002/hep.29288.
    PubMed     Text format    


  186. MASYUK TV, Masyuk AI, Lorenzo Pisarello M, Howard BN, et al
    TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases via cAMP/Galphas signaling.
    Hepatology. 2017 May 23. doi: 10.1002/hep.29284.
    PubMed     Text format     Abstract available


  187. HAYASHI PH, Rockey D, Fontana RJ, Tillmann HL, et al
    Death and Liver Transplantation within Two Years of Onset of Drug-Induced Liver Injury.
    Hepatology. 2017 May 23. doi: 10.1002/hep.29283.
    PubMed     Text format     Abstract available


  188. TSOCHATZIS EA, Bosch J
    Statins in cirrhosis - ready for prime time.
    Hepatology. 2017 May 22. doi: 10.1002/hep.29277.
    PubMed     Text format    


  189. POSSO-OSORIO I, Mendez-Rayo T, Andres Jimenez C, Escobar D, et al
    Hepatic infiltration by silicone in a patient with asia syndrome.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29274.
    PubMed     Text format    


  190. CHO CS, Lombard DB, Lee JH
    SIRT3 as a Regulator of Hepatic Autophagy.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29271.
    PubMed     Text format    


  191. HAN D, Li J, Wang H, Su X, et al
    Circular RNA MTO1 acts as the sponge of miR-9 to suppress hepatocellular carcinoma progression.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29270.
    PubMed     Text format     Abstract available


  192. SAMOYLOVA ML, Nigrini MJ, Dodge JL, Roberts JP, et al
    Biases in the reporting of hcc tumor sizes on the liver transplant waiting list.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29269.
    PubMed     Text format     Abstract available


  193. BUENDIA MA, Armengol C, Cairo S
    Molecular classification of hepatoblastoma and prognostic value of the HB 16-gene signature.
    Hepatology. 2017 May 16. doi: 10.1002/hep.29262.
    PubMed     Text format    


  194. SAFIRI S, Ayubi E
    Dual photon microscopy based quantitation of fibrosis-related parameters (q-FP) to model disease progression in steatohepatitis: Methodological issues.
    Hepatology. 2017 May 16. doi: 10.1002/hep.29261.
    PubMed     Text format    


  195. ZHANG QY, Zhao LP, Tian XX, Yan CH, et al
    The novel intracellular protein CREG inhibits hepatic steatosis, obesity and insulin resistance.
    Hepatology. 2017 May 15. doi: 10.1002/hep.29257.
    PubMed     Text format     Abstract available


  196. SLIJEPCEVIC D, Roscam Abbing RLP, Katafuchi T, Blank A, et al
    Hepatic uptake of conjugated bile acids is mediated by both NTCP and OATPs and modulated by intestinal sensing of plasma bile acid levels in mice.
    Hepatology. 2017 May 12. doi: 10.1002/hep.29251.
    PubMed     Text format     Abstract available


  197. DESERT R, Rohart F, Canal F, Sicard M, et al
    Human Hepatocellular Carcinomas with a Periportal Phenotype Have the Lowest Potential for Early Recurrence after Curative Resection.
    Hepatology. 2017 May 12. doi: 10.1002/hep.29254.
    PubMed     Text format     Abstract available


  198. ZHAO E, Ilyas G, Cingolani F, Choi JH, et al
    Pentamidine Blocks Hepatotoxic Injury in Mice.
    Hepatology. 2017 May 3. doi: 10.1002/hep.29244.
    PubMed     Text format     Abstract available


  199. O'HARA SP, LaRusso NF
    Cellular Senescence, Neuropeptides and Hepatic Fibrosis: Additional Insights into Increasing Complexity.
    Hepatology. 2017 May 2. doi: 10.1002/hep.29243.
    PubMed     Text format    


  200. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:1429-1431.
    PubMed     Text format    


  201. DULAI PS, Singh S, Patel J, Soni M, et al
    Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.
    Hepatology. 2017;65:1557-1565.
    PubMed     Text format     Abstract available


  202. PARK JK, Shao M, Kim MY, Baik SK, et al
    An endoplasmic reticulum protein, Nogo-B, facilitates alcoholic liver disease through regulation of kupffer cell polarization.
    Hepatology. 2017;65:1720-1734.
    PubMed     Text format     Abstract available


  203. XIANG D, Cheng Z, Liu H, Wang X, et al
    Shp2 promotes liver cancer stem cell expansion by augmenting beta-catenin signaling and predicts chemotherapeutic response of patients.
    Hepatology. 2017;65:1566-1580.
    PubMed     Text format     Abstract available


  204. O'HARE EA, Yang R, Yerges-Armstrong LM, Sreenivasan U, et al
    TM6SF2 rs58542926 impacts lipid processing in liver and small intestine.
    Hepatology. 2017;65:1526-1542.
    PubMed     Text format     Abstract available


  205. HOU G, Chen L, Liu G, Li L, et al
    Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in mice.
    Hepatology. 2017;65:1628-1644.
    PubMed     Text format     Abstract available


  206. RAVA M, D'Andrea A, Doni M, Kress TR, et al
    Mutual epithelium-macrophage dependency in liver carcinogenesis mediated by ST18.
    Hepatology. 2017;65:1708-1719.
    PubMed     Text format     Abstract available


    April 2017
  207. WON JK, Yu SJ, Hwang CY, Cho SH, et al
    Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma.
    Hepatology. 2017 Apr 25. doi: 10.1002/hep.29237.
    PubMed     Text format     Abstract available


  208. ZHENG X, Xu F, Liang H, Cao H, et al
    SIRT1/HSF1/HSPs Pathway is Essential for Exenatide-alleviated Lipid-induced Hepatic Endoplasmic Reticulum Stress.
    Hepatology. 2017 Apr 25. doi: 10.1002/hep.29238.
    PubMed     Text format     Abstract available


  209. SRIVASTAVA J, Robertson CL, Ebeid K, Dozmorov M, et al
    A Novel Role of Astrocyte Elevated Gene-1 (AEG-1) in Regulating Non-alcoholic Steatohepatitis (NASH).
    Hepatology. 2017 Apr 24. doi: 10.1002/hep.29230.
    PubMed     Text format     Abstract available


  210. LI S, Dou X, Ning H, Song Q, et al
    SIRT3 Acts As a Negative Regulator of Autophagy Dictating Hepatocyte Susceptibility to Lipotoxicity.
    Hepatology. 2017 Apr 24. doi: 10.1002/hep.29229.
    PubMed     Text format     Abstract available


  211. KOKUDO T, Hasegawa K, Matsuyama Y, Takayama T, et al
    Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: a Japanese nationwide survey.
    Hepatology. 2017 Apr 24. doi: 10.1002/hep.29225.
    PubMed     Text format     Abstract available


  212. PEMBROKE T, Sebastiani G
    Hepatic steatosis, hepatitis C and human immunodeficiency viruses: A complex interplay.
    Hepatology. 2017 Apr 19. doi: 10.1002/hep.29218.
    PubMed     Text format    


  213. KUO F, Park J, Chen A
    Coil Assisted Retrograde Transvenous Obliteration and Partial Splenic Artery Embolization for Hepatic Encephalopathy.
    Hepatology. 2017 Apr 13. doi: 10.1002/hep.29212.
    PubMed     Text format    


  214. SONG Y, Liu C, Liu X, Trottier J, et al
    H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of EpCAM.
    Hepatology. 2017 Apr 13. doi: 10.1002/hep.29209.
    PubMed     Text format     Abstract available


  215. LI Y, Song Y, Zhao M, Guo Y, et al
    A Novel Role for CRTC2 in Hepatic Cholesterol Synthesis via SREBP-2.
    Hepatology. 2017 Apr 10. doi: 10.1002/hep.29206.
    PubMed     Text format     Abstract available


  216. ONO A, Goossens N, Finn RS, Schmidt WN, et al
    Persisting risk of hepatocellular carcinoma after HCV cure monitored by a liver transcriptome signature.
    Hepatology. 2017 Apr 8. doi: 10.1002/hep.29203.
    PubMed     Text format    


  217. ZHANG H, Li ZL, Xing H, Wu MC, et al
    Hepatocellular Carcinoma Surveillance: Sometimes Just Specialists' Incidental Behavior?
    Hepatology. 2017 Apr 7. doi: 10.1002/hep.29200.
    PubMed     Text format    


  218. KIM KH, Choi S, Zhou Y, Kim EY, et al
    Hepatic FXR/SHP Axis Modulates Systemic Glucose and Fatty Acid Homeostasis in Aged Mice.
    Hepatology. 2017 Apr 5. doi: 10.1002/hep.29199.
    PubMed     Text format     Abstract available


  219. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:1081-1083.
    PubMed     Text format    


  220. HADJIHAMBI A, De Chiara F, Hosford PS, Habtetion A, et al
    Ammonia mediates cortical hemichannel dysfunction in rodent models of chronic liver disease.
    Hepatology. 2017;65:1306-1318.
    PubMed     Text format     Abstract available


  221. BALIGAR P, Kochat V, Arindkar SK, Equbal Z, et al
    Bone marrow stem cell therapy partially ameliorates pathological consequences in livers of mice expressing mutant human alpha1-antitrypsin.
    Hepatology. 2017;65:1319-1335.
    PubMed     Text format     Abstract available


  222. SEBODE M, Weidemann S, Wehmeyer M, Lohse AW, et al
    Anti-TNF-alpha for necrotizing sarcoid granulomatosis of the liver.
    Hepatology. 2017;65:1410-1412.
    PubMed     Text format     Abstract available


  223. MITRA A, Yan J, Xia X, Zhou S, et al
    IL6-mediated inflammatory loop reprograms normal to epithelial-mesenchymal transition+ metastatic cancer stem cells in preneoplastic liver of transforming growth factor beta-deficient beta2-spectrin+/- mice.
    Hepatology. 2017;65:1222-1236.
    PubMed     Text format     Abstract available


  224. HALL Z, Bond NJ, Ashmore T, Sanders F, et al
    Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease.
    Hepatology. 2017;65:1165-1180.
    PubMed     Text format     Abstract available


  225. PETTA S, Wong VW, Camma C, Hiriart JB, et al
    Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values.
    Hepatology. 2017;65:1145-1155.
    PubMed     Text format     Abstract available


    March 2017
  226. TOHME S, Yazdani HO, Liu Y, Loughran P, et al
    Hypoxia mediates mitochondrial biogenesis in hepatocellular carcinoma to promote tumor growth via HMGB1 and TLR9 interaction.
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29184.
    PubMed     Text format     Abstract available


  227. LIU P, Ge M, Hu J, Li X, et al
    A functional mTORC1 signaling is indispensable for c-Myc driven hepatocarcinogenesis.
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29183.
    PubMed     Text format     Abstract available


  228. SORIA A, Fabbiani M, Lapadula G, Gori A, et al
    Unexpected viral relapses in HCV-infected patients diagnosed with hepatocellular carcinoma during treatment with DAAs.
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29181.
    PubMed     Text format    


  229. SORIANO G, Bajaj JS
    Grading the range of hepatic encephalopathy from overt to covert: Animals to the Rescue!
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29186.
    PubMed     Text format    


  230. CHANG FM, Wang YP, Lang HC, Tsai CF, et al
    Statins decrease the risk of decompensation in HBV- and HCV-related cirrhosis: A population-based study.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29172.
    PubMed     Text format     Abstract available


  231. SASAKI R, Devhare PB, Steele R, Ray R, et al
    Hepatitis C virus induced CCL5 secretion from macrophages activates hepatic stellate cells.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29170.
    PubMed     Text format     Abstract available


  232. NAHON P, Seror O, Durand-Zaleski I
    Reply to: <<Screening for Hepatocellular carcinoma: A drug safety issue>>.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29174.
    PubMed     Text format    


  233. BRAILLON A
    Screening for hepatocellular carcinoma: A drug safety issue.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29173.
    PubMed     Text format    


  234. DE MATTOS AZ, Miozzo SA, Tovo CV, de Mattos AA, et al
    Risks of proton pump inhibitors for cirrhotic patients - the controversy remains.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29132.
    PubMed     Text format    


  235. MOLLER S, Hove JD
    Assessment of systolic function in the evaluation of patients with cirrhosis.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29163.
    PubMed     Text format    


  236. SINCLAIR M, Schelleman A, Sandhu D, Angus PW, et al
    Regression of hepatocellular adenomas and systemic inflammatory syndrome after cessation of estrogen therapy.
    Hepatology. 2017 Mar 13. doi: 10.1002/hep.29151.
    PubMed     Text format     Abstract available


  237. YANG Y, Zhou Y, Hou J, Bai C, et al
    Hepatic IFIT3 predicts interferon-alpha therapeutic response in patients of hepatocellular carcinoma.
    Hepatology. 2017 Mar 13. doi: 10.1002/hep.29156.
    PubMed     Text format     Abstract available


  238. HE Y, Feng D, Li M, Gao Y, et al
    Hepatic mtDNA-TLR9-microRNA-223 forms a negative feedback loop to limit neutrophil over-activation and acetaminophen hepatotoxicity.
    Hepatology. 2017 Mar 13. doi: 10.1002/hep.29153.
    PubMed     Text format     Abstract available


  239. FLORIMONTE L, Iavarone M, Castellani M, Longo M, et al
    Uncommon extrahepatic metastases from hepatocellular carcinoma.
    Hepatology. 2017 Mar 10. doi: 10.1002/hep.29147.
    PubMed     Text format    


  240. WANG L, Zhang W, Ge CH, Yin RH, et al
    TLR5 signaling restrains T/NKT cell activation and protects against concanavalin A-induced hepatic injury.
    Hepatology. 2017 Mar 8. doi: 10.1002/hep.29140.
    PubMed     Text format     Abstract available


  241. CAMPAGNA F, Montagnese S, Ridola L, Senzolo M, et al
    The animal naming test: An easy tool for the assessment of hepatic encephalopathy.
    Hepatology. 2017 Mar 8. doi: 10.1002/hep.29146.
    PubMed     Text format     Abstract available


  242. LI X, Liu R, Yang J, Sun L, et al
    The role of LncRNA H19 in gender disparity of cholestatic liver injury in Mdr2-/- mice.
    Hepatology. 2017 Mar 8. doi: 10.1002/hep.29145.
    PubMed     Text format     Abstract available


  243. WAN Y, Meng F, Wu N, Zhou T, et al
    Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells.
    Hepatology. 2017 Mar 3. doi: 10.1002/hep.29138.
    PubMed     Text format     Abstract available


  244. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:761-762.
    PubMed     Text format    


  245. MAIERS JL, Kostallari E, Mushref M, deAssuncao TM, et al
    The unfolded protein response mediates fibrogenesis and collagen I secretion through regulating TANGO1 in mice.
    Hepatology. 2017;65:983-998.
    PubMed     Text format     Abstract available


  246. ZHU B, Wei L, Rotile N, Day H, et al
    Combined magnetic resonance elastography and collagen molecular magnetic resonance imaging accurately stage liver fibrosis in a rat model.
    Hepatology. 2017;65:1015-1025.
    PubMed     Text format     Abstract available


  247. ALONSO EM, Horslen SP, Behrens EM, Doo E, et al
    Pediatric acute liver failure of undetermined cause: A research workshop.
    Hepatology. 2017;65:1026-1037.
    PubMed     Text format     Abstract available


  248. KISSELEVA T
    The origin of fibrogenic myofibroblasts in fibrotic liver.
    Hepatology. 2017;65:1039-1043.
    PubMed     Text format     Abstract available


  249. KARVELLAS CJ, Speiser JL, Tremblay M, Lee WM, et al
    Elevated FABP1 serum levels are associated with poorer survival in acetaminophen-induced acute liver failure.
    Hepatology. 2017;65:938-949.
    PubMed     Text format     Abstract available


    February 2017
  250. FAN Z, Li L, Li M, Zhang X, et al
    The histone methyltransferase Suv39h2 contributes to non-alcoholic steatohepatitis in mice.
    Hepatology. 2017 Feb 28. doi: 10.1002/hep.29127.
    PubMed     Text format     Abstract available


  251. YAN F, Wang Y, Zhang W, Chang M, et al
    Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection.
    Hepatology. 2017 Feb 25. doi: 10.1002/hep.29134.
    PubMed     Text format     Abstract available


  252. DAM G, Vilstrup H, Watson H, Jepsen P, et al
    Reply to letter from de Mattos and colleagues: Risks of proton pump inhibitors for cirrhotic patients - the controversy remains.
    Hepatology. 2017 Feb 21. doi: 10.1002/hep.29131.
    PubMed     Text format    


  253. WANG W, Xu MJ, Cai Y, Zhou Z, et al
    Inflammation is independent of steatosis in a murine model of steatohepatitis.
    Hepatology. 2017 Feb 21. doi: 10.1002/hep.29129.
    PubMed     Text format     Abstract available


  254. SABERI B, Dadabhai AS, Durand CM, Philosophe B, et al
    Challenges in Treatment of Hepatitis C among Patients with Hepatocellular Carcinoma.
    Hepatology. 2017 Feb 17. doi: 10.1002/hep.29126.
    PubMed     Text format    


  255. LI H, Zhou ZQ, Yang ZR, Tong DN, et al
    MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma.
    Hepatology. 2017 Feb 14. doi: 10.1002/hep.29116.
    PubMed     Text format     Abstract available


  256. LEMPP FA, Wiedtke E, Qu B, Roques P, et al
    Sodium taurocholate cotransporting polypeptide is the limiting host factor of Hepatitis B Virus infection in macaque and pig hepatocytes.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29112.
    PubMed     Text format     Abstract available


  257. BRUDEN DJ, McMahon BJ, Townshend-Bulson L, Gounder P, et al
    Risk of End Stage Liver Disease, Hepatocellular Carcinoma and Liver-Related Death By Fibrosis Stage in the Hepatitis C Alaska Cohort.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29115.
    PubMed     Text format     Abstract available


  258. WANG H, An P, Xie E, Wu Q, et al
    Characterization of Ferroptosis in Murine Models of Hemochromatosis.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29117.
    PubMed     Text format     Abstract available


  259. GOLDEN-MASON L, Rosen HR
    Galectin-9: Diverse Roles in Hepatic Immune Homeostasis and Inflammation.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29106.
    PubMed     Text format     Abstract available


  260. IWAKIRI Y
    Reply to the Letter to the Editor in regards to the commentary on "The lymphatic system: A new frontier in hepatology".
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29102.
    PubMed     Text format    


  261. YOTTI R, Ripoll C, Benito Y, Catalina MV, et al
    Left ventricular systolic function is associated to sympathetic nervous activity and markers of inflammation in cirrhosis.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29104.
    PubMed     Text format     Abstract available


  262. GOLDSWORTHY MA, Rowe IA
    Patient understanding of hepatocellular carcinoma surveillance.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29103.
    PubMed     Text format    


  263. KUMAR A, Davuluri G, deSilva RN, Engelen MP, et al
    Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29107.
    PubMed     Text format    


  264. KRAWCZYK M, Rau M, Grunhage F, Schattenberg JM, et al
    The ABCB4 p.T175A variant as potential modulator of hepatic fibrosis in patients with chronic liver diseases: Looking beyond the cholestatic realm.
    Hepatology. 2017 Feb 8. doi: 10.1002/hep.29100.
    PubMed     Text format    


  265. CADIER B, Bulsei J, Nahon P, Seror O, et al
    Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.
    Hepatology. 2017 Feb 8. doi: 10.1002/hep.28961.
    PubMed     Text format     Abstract available


  266. LEE MW, Raman SS, Asvadi NH, Siripongsakun S, et al
    Radiofrequency Ablation of Hepatocellular Carcinoma as Bridge Therapy to Liver Transplantation: A Ten Year Intention-to-treat Analysis.
    Hepatology. 2017 Feb 7. doi: 10.1002/hep.29098.
    PubMed     Text format     Abstract available


  267. FERNANDEZ CARRILLO C, Lens S, Llop E, Pascasio JM, et al
    Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of MELD: Analysis of data from the Hepa-C registry.
    Hepatology. 2017 Feb 7. doi: 10.1002/hep.29097.
    PubMed     Text format     Abstract available


  268. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:399-400.
    PubMed     Text format    


  269. ZUBIETE-FRANCO I, Fernandez-Tussy P, Barbier-Torres L, Simon J, et al
    Deregulated neddylation in liver fibrosis.
    Hepatology. 2017;65:694-709.
    PubMed     Text format     Abstract available


  270. KAIKKONEN JE, Wurtz P, Suomela E, Lehtovirta M, et al
    Metabolic profiling of fatty liver in young and middle-aged adults: Cross-sectional and prospective analyses of the Young Finns Study.
    Hepatology. 2017;65:491-500.
    PubMed     Text format     Abstract available


  271. GOLDRING C, Antoine DJ, Bonner F, Crozier J, et al
    Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury.
    Hepatology. 2017;65:710-721.
    PubMed     Text format     Abstract available


  272. HU H, Zhu W, Qin J, Chen M, et al
    Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesis.
    Hepatology. 2017;65:515-528.
    PubMed     Text format     Abstract available


  273. MA JZ, Yang F, Zhou CC, Liu F, et al
    METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6 -methyladenosine-dependent primary MicroRNA processing.
    Hepatology. 2017;65:529-543.
    PubMed     Text format     Abstract available


  274. DEL CHIERICO F, Nobili V, Vernocchi P, Russo A, et al
    Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach.
    Hepatology. 2017;65:451-464.
    PubMed     Text format     Abstract available


    January 2017
  275. VILASECA M, Garcia-Caldero H, Lafoz E, Garcia-Irigoyen O, et al
    The anticoagulant Rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells.
    Hepatology. 2017 Jan 31. doi: 10.1002/hep.29084.
    PubMed     Text format     Abstract available


  276. WANG Y, Vincent R, Yang J, Asgharpour A, et al
    Dual photon microscopy based quantitation of fibrosis-related parameters (q-FP) to model disease progression in steatohepatitis.
    Hepatology. 2017 Jan 30. doi: 10.1002/hep.29090.
    PubMed     Text format     Abstract available


  277. VON LOEFFELHOLZ C, Lieske S, Neuschafer-Rube F, Willmes DM, et al
    The Human Longevity Gene Homolog INDY and Interleukin-6 Interact in Hepatic Lipid Metabolism.
    Hepatology. 2017 Jan 30. doi: 10.1002/hep.29089.
    PubMed     Text format     Abstract available


  278. GORDON-WEEKS AN, Lim SY, Yuzhalin AE, Jones K, et al
    Neutrophils Promote Hepatic Metastasis Growth Through fibroblast growth factor (FGF)2-dependent Angiogenesis.
    Hepatology. 2017 Jan 30. doi: 10.1002/hep.29088.
    PubMed     Text format     Abstract available


  279. HEIMBACH J, Kulik LM, Finn R, Sirlin CB, et al
    Aasld guidelines for the treatment of hepatocellular carcinoma.
    Hepatology. 2017 Jan 28. doi: 10.1002/hep.29086.
    PubMed     Text format    


  280. SHIMIZU Y, Peltzer N, Sevko A, Lafont E, et al
    The linear ubiquitin chain assembly complex acts as a liver tumor suppressor and inhibits hepatocyte apoptosis and hepatitis.
    Hepatology. 2017 Jan 24. doi: 10.1002/hep.29074.
    PubMed     Text format     Abstract available


  281. HARGROVE L, Kennedy L, Demieville J, Jones H, et al
    BDL-induced biliary hyperplasia, hepatic injury and fibrosis are reduced in mast cell deficient Kitw-sh mice.
    Hepatology. 2017 Jan 24. doi: 10.1002/hep.29079.
    PubMed     Text format     Abstract available


  282. WANG Y, Aoki H, Yang J, Peng K, et al
    The role of S1PR2 in bile acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice.
    Hepatology. 2017 Jan 24. doi: 10.1002/hep.29076.
    PubMed     Text format     Abstract available


  283. STEINMETZ C, Kashyap A, Zhivkova N, Alizor H, et al
    Activation of SIRT1 by human chorionic gonadotropin exerts a therapeutic effect on hepatic injury and inflammation.
    Hepatology. 2017 Jan 21. doi: 10.1002/hep.29072.
    PubMed     Text format     Abstract available


  284. SABATE A, Blasi A
    Thromboelastography and blood product usage in cirrhosis with severe coagulopathy.
    Hepatology. 2017 Jan 19. doi: 10.1002/hep.29061.
    PubMed     Text format    


  285. VILLANUEVA C, Graupera I, Aracil C, Alvarado E, et al
    A Randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis.
    Hepatology. 2017 Jan 18. doi: 10.1002/hep.29056.
    PubMed     Text format     Abstract available


  286. DRIVER R, Rowe IA
    What is the benefit of early follow-up after hospitalization for patients with cirrhosis?
    Hepatology. 2017 Jan 18. doi: 10.1002/hep.29060.
    PubMed     Text format    


  287. ARORA P, Basu A, Schmidt ML, Clark GJ, et al
    NS5B Promotes Degradation of the NORE1A Tumor Suppressor to Facilitate Hepatitis C Virus Replication.
    Hepatology. 2017 Jan 16. doi: 10.1002/hep.29049.
    PubMed     Text format     Abstract available


  288. JOO EJ, Chang Y, Ryu S
    Response to NAFLD, hepatotropic viruses and cardio-metabolic risk.
    Hepatology. 2017 Jan 13. doi: 10.1002/hep.29048.
    PubMed     Text format    


  289. LONARDO A, Nascimbeni F, Ballestri S
    NAFLD, hepatotropic viruses and cardio-metabolic risk.
    Hepatology. 2017 Jan 13. doi: 10.1002/hep.29052.
    PubMed     Text format    


  290. LIN L, Ding Y, Wang Y, Wang Z, et al
    Functional lipidomics: palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolism.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29033.
    PubMed     Text format     Abstract available


  291. ATANASOVSKA B, Rensen SS, van der Sijde MR, Marsman G, et al
    A liver-specific long non-coding RNA with a role in cell viability is elevated in human non-alcoholic steatohepatitis.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29034.
    PubMed     Text format     Abstract available


  292. JANG JE, Park HS, Yoo HJ, Baek IJ, et al
    Protective role of endogenous plasmalogens against hepatic steatosis and steatohepatitis.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29039.
    PubMed     Text format     Abstract available


  293. LEFERE S, Hoorens A, Raevens S, Troisi R, et al
    Refractory subacute steatohepatitis after biliopancreatic diversion.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29038.
    PubMed     Text format     Abstract available


  294. BRUSCHI FV, Claudel T, Tardelli M, Caligiuri A, et al
    The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29041.
    PubMed     Text format     Abstract available


  295. PASTORE N, Attanasio S, Granese B, Teckman J, et al
    Activation of JNK pathway aggravates proteotoxicity of hepatic mutant Z alpha1-antitrypsin.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29035.
    PubMed     Text format     Abstract available


  296. YUE X, Ai J, Xu Y, Chen Y, et al
    Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29036.
    PubMed     Text format     Abstract available


  297. ALKHOURI N, Feldstein AE
    Treating Nonalcoholic Steatohepatitis (NASH) in Children: Not a Cinch Task.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29043.
    PubMed     Text format     Abstract available


  298. STRAZZABOSCO M, Allen JI, Teisberg EO
    Value based care in hepatology.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29042.
    PubMed     Text format     Abstract available


  299. VARRASSO G, Schiavetti A, Lanciotti S, Sapio M, et al
    Propranolol as First Line Treatment for Life-threatening Diffuse Infantile Hepatic Hemangioma: A Case Report.
    Hepatology. 2017 Jan 5. doi: 10.1002/hep.29028.
    PubMed     Text format    


  300. MARONI L, Hohenester SD, van de Graaf SF, Tolenaars D, et al
    Knockout of the Primary Sclerosing Cholangitis-Risk Gene Fut2 Causes Liver Disease in Mice.
    Hepatology. 2017 Jan 5. doi: 10.1002/hep.29029.
    PubMed     Text format     Abstract available


  301. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:1-3.
    PubMed     Text format    


  302. ALCARAZ-QUILES J, Titos E, Casulleras M, Pavesi M, et al
    Polymorphisms in the IL-1 gene cluster influence systemic inflammation in patients at risk for acute-on-chronic liver failure.
    Hepatology. 2017;65:202-216.
    PubMed     Text format     Abstract available


  303. DECARIS ML, Li KW, Emson CL, Gatmaitan M, et al
    Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood.
    Hepatology. 2017;65:78-88.
    PubMed     Text format     Abstract available


  304. NAVARRO VJ, Khan I, Bjornsson E, Seeff LB, et al
    Liver injury from herbal and dietary supplements.
    Hepatology. 2017;65:363-373.
    PubMed     Text format     Abstract available


  305. WANG J, Koh HW, Zhou L, Bae UJ, et al
    Sirtuin 2 aggravates postischemic liver injury by deacetylating mitogen-activated protein kinase phosphatase-1.
    Hepatology. 2017;65:225-236.
    PubMed     Text format     Abstract available


  306. AJMERA V, Perito ER, Bass NM, Terrault NA, et al
    Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease.
    Hepatology. 2017;65:65-77.
    PubMed     Text format     Abstract available


  307. LEUNG JC, Loong TC, Wei JL, Wong GL, et al
    Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients.
    Hepatology. 2017;65:54-64.
    PubMed     Text format     Abstract available


    December 2016
  308. SHUNG DL, Garcia-Tsao G
    Liver Capsule: Portal Hypertension and Varices: Pathogenesis, Stages and Management.
    Hepatology. 2016 Dec 29. doi: 10.1002/hep.29026.
    PubMed     Text format    


  309. LI N, Zhou ZS, Shen Y, Xu J, et al
    Inhibition of the SREBP pathway suppresses hepatocellular carcinoma through repressing inflammation.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29018.
    PubMed     Text format     Abstract available


  310. MCCOMMIS KS, Hodges WT, Brunt EM, Nalbantoglu I, et al
    Targeting the Mitochondrial Pyruvate Carrier Attenuates Fibrosis in a Mouse Model of Nonalcoholic Steatohepatitis.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29025.
    PubMed     Text format     Abstract available


  311. LI D, Liu X, Zhou J, Hu J, et al
    LncRNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of ERK and YB-1 to enhance hepatocarcinogenesis.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29010.
    PubMed     Text format     Abstract available


  312. TANDON P, Raman M, Mourtzakis M, Merli M, et al
    A Practical Approach to Nutritional Screening and Assessment in Cirrhosis.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29003.
    PubMed     Text format     Abstract available


  313. HAUSSINGER D, Keitel V
    Dual role of the bile acid receptor TGR5 for hepatic lipid metabolism in feast and famine.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29017.
    PubMed     Text format    


  314. WANG KS, Tiao G, Bass LM, Hertel PM, et al
    Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29019.
    PubMed     Text format     Abstract available


  315. QIU YL, Gong JY, Feng JY, Wang RX, et al
    Defects in MYO5B are associated with a spectrum of previously undiagnosed low gamma-glutamyltransferase cholestasis.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29020.
    PubMed     Text format     Abstract available


  316. CILLO U, Vitale A, Polacco M, Fasolo E, et al
    Liver transplantation for hepatocellular carcinoma through the lens of transplant benefit.
    Hepatology. 2016 Dec 23. doi: 10.1002/hep.28998.
    PubMed     Text format    


  317. AYUBI E, Safiri S, Sani M, Doosti-Irani A, et al
    Effect of Metabolic syndrome on cardiovascular, hepatic events and death in CHB patients: Methodological issues.
    Hepatology. 2016 Dec 23. doi: 10.1002/hep.29001.
    PubMed     Text format    


  318. BERZIGOTTI A, Albillos A, Villanueva C, Genesca J, et al
    Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The sportdiet study.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28992.
    PubMed     Text format     Abstract available


  319. MICHALOPOULOS GK
    Hepatostat: Liver regeneration and normal liver tissue maintenance.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28988.
    PubMed     Text format     Abstract available


  320. GUPTA R, Gupta J
    Strategies to improve survival of patients with intrahepatic cholangiocarcinoma undergoing liver transplantation.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28994.
    PubMed     Text format    


  321. SAPISOCHIN G, Bruix J
    In response to: Strategies to improve survival of patients with intrahepatic cholangiocarcinoma undergoing liver transplantation.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28993.
    PubMed     Text format    


  322. MORIS D, Felekouras E
    Ignore reality but not the consequences of its ignorance: Broaden Guidelines in surgery of Hepatocellular carcinoma.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28984.
    PubMed     Text format     Abstract available


  323. SAVALE L, Sattler C, Coilly A, Conti F, et al
    Long-term outcome in liver transplantation candidates with portopulmonary hypertension.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28990.
    PubMed     Text format     Abstract available


  324. TAO J, Zhang R, Singh S, Poddar M, et al
    Targeting beta-catenin in hepatocellular cancers induced by co-expression of mutant beta-catenin and K-Ras in mice.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28975.
    PubMed     Text format     Abstract available


  325. BRIL F, Barb D, Portillo-Sanchez P, Biernacki D, et al
    Metabolic and Histological Implications of Intrahepatic Triglyceride Content in Nonalcoholic Fatty Liver Disease.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28985.
    PubMed     Text format     Abstract available


  326. MORZYGLOD L, Cauzac M, Popineau L, Denechaud PD, et al
    Grb14 inhibition triggers insulin-induced mouse hepatocyte proliferation and is associated with hepatocellular carcinoma.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28972.
    PubMed     Text format     Abstract available


  327. YAN FJ, Zhang XJ, Wang WX, Ji YX, et al
    The E3 ligase TRIM8 targets TAK1 to promote insulin resistance and steatohepatitis.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28971.
    PubMed     Text format     Abstract available


  328. KAFFE E, Katsifa A, Xylourgidis N, Ninou I, et al
    Hepatocyte Autotaxin expression promotes liver fibrosis and cancer.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28973.
    PubMed     Text format     Abstract available


  329. BUSCH CJ, Hendrikx T, Weismann D, Jackel S, et al
    Malondialdehyde epitopes are sterile mediators of hepatic inflammation in hypercholesterolemic mice.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28970.
    PubMed     Text format     Abstract available


  330. FAN W, Yang H, Liu T, Wang J, et al
    Prohibitin 1 Suppresses Liver Cancers Tumorigenesis in Mice and Human Hepatocellular and Cholangiocarcinoma cells.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28964.
    PubMed     Text format     Abstract available


  331. PRICE JC, Ma Y, Scherzer R, Korn N, et al
    HIV-infected and Uninfected Adults with Non-Genotype 3 Hepatitis C Virus Have Less Hepatic Steatosis than Adults with Neither Infection.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28968.
    PubMed     Text format     Abstract available


  332. BONKOVSKY HL, Kleiner DE, Gu J, Odin JA, et al
    Clinical Presentations and Outcomes of Bile Duct Loss caused by Drugs and Herbal and Dietary Supplements.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28967.
    PubMed     Text format     Abstract available


  333. JANSEN PL, Ghallab A, Vartak N, Reif R, et al
    The ascending pathophysiology of cholestatic liver disease.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28965.
    PubMed     Text format     Abstract available


  334. TAHARA Y, Shibata S
    Abnormal tuning of the hepatic circadian metabolic rhythms in lung cancer.
    Hepatology. 2016 Dec 10. doi: 10.1002/hep.28982.
    PubMed     Text format    


  335. HERNAEZ R, El-Serag H, DeBakey ME
    Hepatocellular Carcinoma Surveillance: The Road Ahead.
    Hepatology. 2016 Dec 10. doi: 10.1002/hep.28983.
    PubMed     Text format    



  336. 2016 Hepatology referees (volumes 63 and 64).
    Hepatology. 2016;64:2280-2285.
    PubMed     Text format    


  337. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:1829-1830.
    PubMed     Text format    


    November 2016
  338. VALDECANTOS MP, Pardo V, Ruiz L, Castro-Sanchez L, et al
    A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice.
    Hepatology. 2016 Nov 23. doi: 10.1002/hep.28962.
    PubMed     Text format     Abstract available


  339. KLEBANOFF MJ, Corey KE, Chhatwal J, Kaplan LM, et al
    Bariatric Surgery for Nonalcoholic Steatohepatitis: A Clinical and Cost-Effectiveness Analysis.
    Hepatology. 2016 Nov 23. doi: 10.1002/hep.28958.
    PubMed     Text format     Abstract available


  340. TRAN M, Wang L
    Preserving LXR by Inhibiting T39: A step closer to treating atherosclerosis and steatohepatitis?
    Hepatology. 2016 Nov 17. doi: 10.1002/hep.28946.
    PubMed     Text format    


  341. ASKGAARD G, Leon DA, Kjaer MS, Deleuran T, et al
    Risk for alcoholic liver cirrhosis after an initial hospital contact with alcohol problems: A nationwide prospective cohort study.
    Hepatology. 2016 Nov 16. doi: 10.1002/hep.28943.
    PubMed     Text format     Abstract available


  342. NEWBERRY EP, Xie Y, Kennedy SM, Graham MJ, et al
    Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in Liver fatty acid binding protein null mice.
    Hepatology. 2016 Nov 14. doi: 10.1002/hep.28941.
    PubMed     Text format     Abstract available


  343. VAN ASTEN M, Verhaegh P, Koek G, Verbeek J, et al
    The increasing burden of NAFLD fibrosis in the general population: Time to bridge the gap between hepatologists and primary care.
    Hepatology. 2016 Nov 10. doi: 10.1002/hep.28940.
    PubMed     Text format    


  344. CALDWELL S, Lisman T
    The cirrhotic platelet: Shedding light on an enigma.
    Hepatology. 2016 Nov 7. doi: 10.1002/hep.28931.
    PubMed     Text format    


  345. KIM JH, Sinn DH, Kang W, Gwak GY, et al
    Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28916.
    PubMed     Text format     Abstract available


  346. YAN S, Tang J, Zhang Y, Wang Y, et al
    Prostaglandin E2 promotes hepatic bile acid synthesis by an E prostanoid receptor 3-mediated hepatocyte nuclear receptor 4alpha/cholesterol 7alpha-hydroxylase pathway in mice.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28928.
    PubMed     Text format     Abstract available


  347. MASSEY VL, Dolin CE, Poole LG, Hudson SV, et al
    The hepatic "matrisome" responds dynamically to injury: Characterization of transitional changes to the extracellular matrix in mice.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28918.
    PubMed     Text format     Abstract available


  348. NIU Y, Xu M, Slagle BL, Huang H, et al
    Farnesoid X receptor ablation sensitizes mice to hepatitis b virus X protein-induced hepatocarcinogenesis.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28924.
    PubMed     Text format     Abstract available


  349. DESBOROUGH MJ, Kahan BC, Stanworth SJ, Jairath V, et al
    Fibrinogen as an independent predictor of mortality in decompensated cirrhosis and bleeding.
    Hepatology. 2016 Nov 3. doi: 10.1002/hep.28915.
    PubMed     Text format    


  350. DROLZ A, Fuhrmann V
    "Fibrinogen as an independent predictor of mortality in decompensated cirrhosis and bleeding".
    Hepatology. 2016 Nov 3. doi: 10.1002/hep.28914.
    PubMed     Text format    


  351. CAI WY, Lin LY, Hao H, Zhang SM, et al
    YAP-TEAD and HNF4alpha repress reciprocally to regulate hepatocarcinogenesis.
    Hepatology. 2016 Nov 3. doi: 10.1002/hep.28911.
    PubMed     Text format     Abstract available


  352. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:1395-1397.
    PubMed     Text format    


  353. QURESHI MA, Kim YO, Schuppan D
    Hepatocellular carcinoma in nonalcoholic fatty liver disease: A link between oxidative stress and T-cell suppression.
    Hepatology. 2016;64:1794-1797.
    PubMed     Text format    


  354. TAO J, Xu E, Zhao Y, Singh S, et al
    Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant beta-catenin.
    Hepatology. 2016;64:1587-1605.
    PubMed     Text format     Abstract available


    October 2016
  355. GARCIA-TSAO G, Abraldes J, Berzigotti A, Bosch J, et al
    Portal Hypertensive Bleeding in Cirrhosis: Risk Stratification, Diagnosis and Management - 2016 Practice Guidance by the American Association for the Study of Liver Diseases.
    Hepatology. 2016 Oct 27. doi: 10.1002/hep.28906.
    PubMed     Text format    


  356. KALAFATELI M, Wickham F, Burniston M, Cholongitas E, et al
    Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: The rfh cirrhosis Gfr.
    Hepatology. 2016 Oct 25. doi: 10.1002/hep.28891.
    PubMed     Text format     Abstract available


  357. TANDON P, Reddy KR, O'Leary JG, Garcia-Tsao G, et al
    A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28900.
    PubMed     Text format     Abstract available


  358. ATIQ O, Tiro J, Yopp AC, Muffler A, et al
    An Assessment of Benefits and Harms of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28895.
    PubMed     Text format     Abstract available


  359. SUMAZIN P, Chen Y, Trevino LR, Sarabia SF, et al
    Genomic Analysis of Hepatoblastoma Identifies Distinct Molecular and Prognostic Subgroups.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28888.
    PubMed     Text format     Abstract available


  360. KIMER N, Pedersen JS, Busk TM, Gluud LL, et al
    Rifaximin has no effect on hemodynamics in decompensated cirrhosis - A randomized, double blind, placebo controlled trial.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28898.
    PubMed     Text format     Abstract available


  361. SUN Q, Loughran P, Shapiro R, Shrivastava IH, et al
    Redox-dependent regulation of hepatocyte AIM2 inflammasome activation in sterile liver injury in mice.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28893.
    PubMed     Text format     Abstract available


  362. KE S, Chen S, Dong Z, Hong CS, et al
    Erythrocytosis in hepatocellular carcinoma portends poor prognosis by respiratory dysfunction secondary to mitochondrial DNA mutations.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28889.
    PubMed     Text format     Abstract available


  363. LABONTE AC, Sung SJ, Jennelle LT, Dandekar AP, et al
    Expression of scavenger receptor-AI promotes alternative activation of murine macrophages to limit hepatic inflammation and fibrosis.
    Hepatology. 2016 Oct 22. doi: 10.1002/hep.28873.
    PubMed     Text format     Abstract available


  364. PARIKH ND, Marshall VD, Singal AG, Nathan H, et al
    Survival and Cost-Effectiveness of Sorafenib Therapy in Advanced Hepatocellular Carcinoma: An Analysis of the SEER-Medicare Database.
    Hepatology. 2016 Oct 22. doi: 10.1002/hep.28881.
    PubMed     Text format     Abstract available


  365. GARCIA-TSAO G
    Empowering Women - Perspective from a Hepatologist.
    Hepatology. 2016 Oct 22. doi: 10.1002/hep.28875.
    PubMed     Text format    


  366. BERGMANN J, Muller M, Baumann N, Reichert M, et al
    IL-6 trans-signaling is essential for the development of hepatocellular carcinoma.
    Hepatology. 2016 Oct 22. doi: 10.1002/hep.28874.
    PubMed     Text format     Abstract available


  367. MAROT A, Vandenbulcke H, Knebel JF, Doerig C, et al
    External validation of the nomogram for individualized prediction of HCC occurrence in patients with HCV-related compensated cirrhosis.
    Hepatology. 2016 Oct 13. doi: 10.1002/hep.28865.
    PubMed     Text format    


  368. HASLAM DB
    Non-alcoholic steatohepatitis and the intestinal microbiota.
    Hepatology. 2016 Oct 7. doi: 10.1002/hep.28864.
    PubMed     Text format    


  369. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:1011-3.
    PubMed     Text format    


    September 2016
  370. ALI KHAN M, Cholankeril G, Howden CW
    Are proton pump inhibitors a threat for spontaneous bacterial peritonitis and hepatic encephalopathy in cirrhosis? Not so fast.
    Hepatology. 2016 Sep 30. doi: 10.1002/hep.28858.
    PubMed     Text format    


  371. LAINE F, Ruivard M, Loustaud-Ratti V, Bonnet F, et al
    Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients.
    Hepatology. 2016 Sep 29. doi: 10.1002/hep.28856.
    PubMed     Text format     Abstract available


  372. CHENG JY, Wong VW, Tse YK, Chim AM, et al
    Metabolic syndrome increases cardiovascular event but not hepatic event and death in patients with chronic hepatitis B.
    Hepatology. 2016 Sep 29. doi: 10.1002/hep.28778.
    PubMed     Text format     Abstract available


  373. PONZETTO A, Srinivasan RS
    Risk factors for hepatocellular carcinoma.
    Hepatology. 2016 Sep 28. doi: 10.1002/hep.28854.
    PubMed     Text format    


  374. LO GH
    The risk of bleeding after invasive procedures in cirrhotics with severe coagulopathy.
    Hepatology. 2016 Sep 26. doi: 10.1002/hep.28855.
    PubMed     Text format    


  375. CUSI K
    Nonalcoholic Steatohepatitis in Non-Obese Patients: Not So Different After All.
    Hepatology. 2016 Sep 20. doi: 10.1002/hep.28839.
    PubMed     Text format    


  376. RAPARELLI V, Basili S, Carnevale R, Napoleone L, et al
    Low-grade endotoxemia and platelet activation in cirrhosis.
    Hepatology. 2016 Sep 19. doi: 10.1002/hep.28853.
    PubMed     Text format     Abstract available


  377. LI D, Li W, Hui L
    Hybrid hepatocyte: A newly identified player for regeneration in hepatic injuries.
    Hepatology. 2016 Sep 19. doi: 10.1002/hep.28837.
    PubMed     Text format     Abstract available


  378. MULLIGAN DC
    The ongoing quest to find the appropriate patients to transplant with hepatocellular carcinoma: Milan to san Francisco to Toronto and beyond.
    Hepatology. 2016 Sep 19. doi: 10.1002/hep.28841.
    PubMed     Text format    


  379. AMARAPURKAR D, Somani V, Shah A
    Do we need to correct coagulation abnormalities prophylactically in cirrhotics undergoing invasive procedures? - A Dilemma.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28830.
    PubMed     Text format    


  380. EGUCHI A, Lazaro RG, Wang J, Kim J, et al
    Extracellular vesicles released by hepatocytes from gastric infusion model of ALD contain a miRNA barcode that can be detected in blood.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28838.
    PubMed     Text format     Abstract available


  381. GASTALDELLI A, Gaggini M, Daniele G, Ciociaro D, et al
    Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic PET study.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28827.
    PubMed     Text format     Abstract available


  382. ABRALDES JG, Bureau C, Stefanescu H, Augustin S, et al
    Non-invasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The "Anticipate" study.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28824.
    PubMed     Text format     Abstract available


  383. AZZARITI A, Mancarella S, Porcelli L, Elisa Quatrale A, et al
    Hepatic Stellate Cells Induce HCC Cell Resistance to Sorafenib through the Laminin-332/alpha3 Integrin Axis recovery of FAK Ubiquitination.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28835.
    PubMed     Text format     Abstract available


  384. KULKARNI SR, Soroka CJ, Hagey LR, Boyer JL, et al
    Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid fed mouse model of cholestasis.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28826.
    PubMed     Text format     Abstract available


  385. TANAKA S, Hikita H, Tatsumi T, Sakamori R, et al
    Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease.
    Hepatology. 2016 Sep 16. doi: 10.1002/hep.28820.
    PubMed     Text format     Abstract available


  386. KAMINSKY P, Preiss J, Sasatomi E, Gerber DA, et al
    Biliary Adenofibroma: A Rare Hepatic Lesion with Malignant Features.
    Hepatology. 2016 Sep 15. doi: 10.1002/hep.28818.
    PubMed     Text format    


  387. RUSSO MW, Koteish A, Fuchs M, Reddy G, et al
    Workforce in Hepatology: Update and a critical need for more information.
    Hepatology. 2016 Sep 15. doi: 10.1002/hep.28810.
    PubMed     Text format     Abstract available


  388. HO CM, Chen HL
    Expression of Glutamine Synthetase in Hepatocyte Progenitor Cells Derived from Canal of Hering.
    Hepatology. 2016 Sep 12. doi: 10.1002/hep.28805.
    PubMed     Text format    


  389. TREVISANI F, Bucci L, Garuti F
    Is it time to extend criteria for hepatic resection in the treatment of hepatocellular carcinoma?
    Hepatology. 2016 Sep 12. doi: 10.1002/hep.28804.
    PubMed     Text format    


  390. SOLINAS A, Calvisi DF
    PD-L1 expression in hepatocellular carcinoma: A prognostic marker and therapeutic target for liver cancer?
    Hepatology. 2016 Sep 12. doi: 10.1002/hep.28803.
    PubMed     Text format    


  391. RENOU C, Lesgourgues B, Macaigne G, Pauwels A, et al
    Hepatitis E in decompensated alcoholic cirrhosis.
    Hepatology. 2016 Sep 12. doi: 10.1002/hep.28792.
    PubMed     Text format    


  392. PASCALE RM, Feo F, Calvisi DF
    An infernal crosstalk between oncogenic beta-catenin and c-Met in hepatocellular carcinoma: Evidence from mouse modeling.
    Hepatology. 2016 Sep 6. doi: 10.1002/hep.28790.
    PubMed     Text format    


  393. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:703-5.
    PubMed     Text format    


    August 2016
  394. TORNER A, Stokkeland K, Svensson A, Dickman PW, et al
    The underreporting of hepatocellular carcinoma to the Cancer Register and a log-linear model to estimate a more correct incidence.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28775.
    PubMed     Text format     Abstract available


  395. OKABE H, Yang J, Sylakowski K, Yovchev M, et al
    Wnt signaling regulates hepatobiliary repair following cholestatic liver injury in mice.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28774.
    PubMed     Text format     Abstract available


  396. LAUSCHKE VM, Vorrink SU, Moro SM, Reyazee F, et al
    Massive rearrangements of cellular miRNA signatures are key drivers of hepatocyte dedifferentiation.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28780.
    PubMed     Text format     Abstract available


  397. LALEMAN W, Trebicka J, Verbeke L
    Evolving insights in the pathophysiology of complications of cirrhosis: The Farnesoid-X receptor (FXR) to the rescue?
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28771.
    PubMed     Text format    


  398. FARVARDIN S, Patel J, Khambaty M, Yerokun OA, et al
    Patient-Reported Barriers are Associated with Lower HCC Surveillance Rates in Patients with Cirrhosis.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28770.
    PubMed     Text format     Abstract available


  399. SALLOUM S, Holmes JA, Jindal R, Bale SS, et al
    HIV/HCV in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28766.
    PubMed     Text format     Abstract available


  400. GOLDBERG DS, Taddei TH, Serper M, Mehta R, et al
    Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28765.
    PubMed     Text format     Abstract available


  401. CHEN HA, Kuo TC, Tseng CF, Ma JT, et al
    ANGPTL1 Antagonizes MET Receptor Activity to Repress Sorafenib Resistance and Cancer Stemness in Hepatocellular Carcinoma Cells.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28773.
    PubMed     Text format     Abstract available


  402. GONZALES E, Taylor SA, Davit-Spraul A, Thebaut A, et al
    MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28779.
    PubMed     Text format     Abstract available


  403. CLERBAUX LA, Manco R, Leclercq I
    Upstream regulators of hepatic Wnt/beta-catenin activity control liver metabolic zonation, development and regeneration.
    Hepatology. 2016 Aug 12. doi: 10.1002/hep.28763.
    PubMed     Text format    


  404. MIKOLAJCZYK AE, Farnan JM, McConville JF, Jensen DM, et al
    Novel Educational Interventions in Residency Increase Knowledge of Chronic Liver Disease and Career Interest in Hepatology.
    Hepatology. 2016 Aug 10. doi: 10.1002/hep.28741.
    PubMed     Text format     Abstract available


  405. BIHARI C, Anand L, Rooge S, Kumar D, et al
    Bone Marrow Stem Cells and its Niche Components are Adversely Affected in Advanced Cirrhosis of Liver.
    Hepatology. 2016 Aug 3. doi: 10.1002/hep.28754.
    PubMed     Text format     Abstract available


  406. CLARIA J, Stauber RE, Coenraad MJ, Moreau R, et al
    systemic inflammation in decompensated cirrhosis. Characterization and role in acute-on-chronic liver failure.
    Hepatology. 2016 Aug 2. doi: 10.1002/hep.28740.
    PubMed     Text format     Abstract available


  407. DROLZ A, Fuhrmann V
    Reply to "Anticoagulation with i.v. unfractionated heparin and major bleeding in cirrhosis".
    Hepatology. 2016 Aug 2. doi: 10.1002/hep.28757.
    PubMed     Text format    


  408. SAPISOCHIN G, Facciuto M, Rubbia-Brandt L, Marti J, et al
    Liver transplantation for "very early" intrahepatic cholangiocarcinoma. international retrospective study supporting a prospective assessment.
    Hepatology. 2016 Aug 2. doi: 10.1002/hep.28744.
    PubMed     Text format     Abstract available


  409. HU W, Zhang W, Chen Y, Rana U, et al
    Nogo-B receptor deficiency increases LXRalpha nuclear translocation and hepatic lipogenesis via an AMPKalpha-dependent pathway.
    Hepatology. 2016 Aug 2. doi: 10.1002/hep.28747.
    PubMed     Text format     Abstract available



  410. Correction: Mixed lineage kinase 3 mediates release of C-X-C motif ligand 10-bearing chemotactic extracellular vesicles from lipotoxic hepatocytes.
    Hepatology. 2016;64:702.
    PubMed     Text format    


  411. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:325-7.
    PubMed     Text format    


    July 2016
  412. QI X, De Stefano V, Guo X
    Anticoagulation with i.v. unfractionated heparin and major bleeding in cirrhosis.
    Hepatology. 2016 Jul 30. doi: 10.1002/hep.28743.
    PubMed     Text format    


  413. DAM G, Vilstrup H, Watson H, Jepsen P, et al
    Proton Pump Inhibitors as a Risk Factor for Hepatic Encephalopathy and Spontaneous Bacterial Peritonitis in Cirrhosis Patients With Ascites.
    Hepatology. 2016 Jul 30. doi: 10.1002/hep.28737.
    PubMed     Text format     Abstract available


  414. LI L, Piontek K, Ishida M, Fausther M, et al
    Extracellular vesicles carry miR-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model.
    Hepatology. 2016 Jul 30. doi: 10.1002/hep.28735.
    PubMed     Text format     Abstract available


  415. MAROT A, Trepo E, Doerig C, Moreno C, et al
    SEMS should be considered in patients with cirrhosis and uncontrolled variceal bleeding.
    Hepatology. 2016 Jul 30. doi: 10.1002/hep.28738.
    PubMed     Text format    


  416. DUNCAN SA
    Multipotent stem cells and their lineage restriction to hepatocytes.
    Hepatology. 2016 Jul 12. doi: 10.1002/hep.28727.
    PubMed     Text format    


  417. SUGIYAMA M, Kanto T
    Dual blockade of HCV entry at a gatekeeper of hepatocytes - Not only a preventive but also therapeutic target of CLDN-1.
    Hepatology. 2016 Jul 12. doi: 10.1002/hep.28726.
    PubMed     Text format    


  418. PORAT-SHLIOM N, Tietgens AJ, Van Itallie CM, Vitale-Cross L, et al
    Liver Kinase B1 regulates hepatocellular tight junction distribution and function in vivo.
    Hepatology. 2016 Jul 11. doi: 10.1002/hep.28724.
    PubMed     Text format     Abstract available


  419. KOPPE C, Verheugd P, Gautheron J, Reisinger F, et al
    IKKalpha/beta control biliary homeostasis and hepatocarcinogenesis in mice by phosphorylating the cell-death mediator RIPK1.
    Hepatology. 2016 Jul 11. doi: 10.1002/hep.28723.
    PubMed     Text format     Abstract available


  420. LANGBERG KM, Taddei TH
    Balancing quality with quantity: The role of palliative care in managing decompensated cirrhosis.
    Hepatology. 2016 Jul 7. doi: 10.1002/hep.28717.
    PubMed     Text format    


  421. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:1-3.
    PubMed     Text format    


    June 2016
  422. CUERVO H, Nielsen CM, Simonetto DA, Ferrell L, et al
    Endothelial Notch signaling is essential to prevent hepatic vascular malformations in mice.
    Hepatology. 2016 Jun 30. doi: 10.1002/hep.28713.
    PubMed     Text format     Abstract available


  423. CALDERARO J, Rousseau B, Amaddeo G, Mercey M, et al
    PD-L1 expression in hepatocellular carcinoma: Relationship with clinical and pathological features.
    Hepatology. 2016 Jun 30. doi: 10.1002/hep.28710.
    PubMed     Text format     Abstract available


  424. WU D, Liu G, Liu Y, Saiyin H, et al
    Zinc finger protein 191 inhibits hepatocellular carcinoma metastasis via discs large 1-mediated yes associated protein inactivation.
    Hepatology. 2016 Jun 30. doi: 10.1002/hep.28708.
    PubMed     Text format     Abstract available


  425. ARAB JP, Karpen SJ, Dawson PA, Arrese M, et al
    Bile acids & nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives.
    Hepatology. 2016 Jun 30. doi: 10.1002/hep.28709.
    PubMed     Text format     Abstract available


  426. DONEPUDI AC, Boehme S, Li F, Chiang JY, et al
    G protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis.
    Hepatology. 2016 Jun 28. doi: 10.1002/hep.28707.
    PubMed     Text format     Abstract available


  427. KALAMBOKIS GN, Oikonomou A, Christou L, Baltayiannis G, et al
    High von Willebrand factor antigen levels and procoagulant imbalance may be involved in both increasing severity of cirrhosis and portal vein thrombosis.
    Hepatology. 2016 Jun 27. doi: 10.1002/hep.28703.
    PubMed     Text format    


  428. GANNE-CARRIE N, Layese R, Bourcier V, Cagnot C, et al
    Nomogram for individualized prediction of hepatocellular carcinoma occurrence in HCV-cirrhosis (ANRS CO12 CirVir).
    Hepatology. 2016 Jun 27. doi: 10.1002/hep.28702.
    PubMed     Text format     Abstract available


  429. HANNAH WN JR, Harrison SA
    Non-invasive Imaging Methods to Determine Severity of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Hepatology. 2016 Jun 24. doi: 10.1002/hep.28699.
    PubMed     Text format     Abstract available


  430. KANG DJ, Betrapally NS, Ghosh SA, Sartor RB, et al
    Gut microbiota drive the development of neuro-inflammatory response in cirrhosis.
    Hepatology. 2016 Jun 23. doi: 10.1002/hep.28696.
    PubMed     Text format     Abstract available


  431. SUK KT, Yoon JH, Kim MY, Kim CW, et al
    Transplantation with Autologous Bone Marrow-Derived Mesenchymal Stem Cells for Alcoholic Cirrhosis: Phase 2 Trial.
    Hepatology. 2016 Jun 23. doi: 10.1002/hep.28693.
    PubMed     Text format     Abstract available


  432. ZHANG H, Xing Z, Mani SK, Bancel B, et al
    RNA helicase DDX5 regulates PRC2/HOTAIR function in Hepatitis B Virus infection and hepatocarcinogenesis.
    Hepatology. 2016 Jun 23. doi: 10.1002/hep.28698.
    PubMed     Text format     Abstract available


  433. SPENGLER EK, Kleiner DE, Fontana RJ
    Vemurafenib-induced Granulomatous hepatitis.
    Hepatology. 2016 Jun 23. doi: 10.1002/hep.28692.
    PubMed     Text format    


  434. CUI J, Chen CH, Lo MT, Schork N, et al
    Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study.
    Hepatology. 2016 Jun 17. doi: 10.1002/hep.28674.
    PubMed     Text format     Abstract available


  435. DI PASCOLI M, Zampieri F, Verardo A, Pesce P, et al
    Inhibition of EETs production in cirrhotic rats has beneficial effects on portal hypertension by reducing splanchnic vasodilation.
    Hepatology. 2016 Jun 16. doi: 10.1002/hep.28686.
    PubMed     Text format     Abstract available


  436. THOMSEN MK, Nandakumar R, Stadler D, Malo A, et al
    Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection.
    Hepatology. 2016 Jun 16. doi: 10.1002/hep.28685.
    PubMed     Text format     Abstract available


  437. PLOEGER C, Waldburger N, Fraas A, Goeppert B, et al
    Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin-6 signaling in hepatocellular carcinoma.
    Hepatology. 2016 Jun 16. doi: 10.1002/hep.28684.
    PubMed     Text format     Abstract available


  438. SETIAWAN VW, Stram DO, Porcel J, Lu SC, et al
    Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The Multiethnic Cohort.
    Hepatology. 2016 Jun 15. doi: 10.1002/hep.28677.
    PubMed     Text format     Abstract available


  439. FENG S, Demetris AJ, Spain KM, Kanaparthi S, et al
    Five year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R.
    Hepatology. 2016 Jun 15. doi: 10.1002/hep.28681.
    PubMed     Text format     Abstract available


  440. MARQUARDT JU
    Deconvolution of the cellular origin in hepatocellular carcinoma - hepatocytes take the center stage.
    Hepatology. 2016 Jun 10. doi: 10.1002/hep.28671.
    PubMed     Text format    


  441. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:1749-1751.
    PubMed     Text format    


    May 2016
  442. INZAUGARAT ME, Wree A, Feldstein AE
    Hepatocyte mitochondrial DNA released in microparticles and TLR9 activation: A link between lipotoxicity and inflammation during NASH.
    Hepatology. 2016 May 30. doi: 10.1002/hep.28666.
    PubMed     Text format    


  443. CHIU DK, Xu IM, Lai RK, Tse AP, et al
    Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28655.
    PubMed     Text format     Abstract available


  444. SUNG FY, Lan CY, Huang CJ, Lin CL, et al
    Progressive accumulation of mutations in the hepatitis B virus genome and its impact for time to diagnosis of hepatocellular carcinoma.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28654.
    PubMed     Text format     Abstract available


  445. ZEISEL MB, Baumert TF
    Translation and protein expression of lncRNAs: Impact for liver disease and hepatocellular carcinoma.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28653.
    PubMed     Text format    


  446. IWAKIRI Y
    The Lymphatic system: A new frontier in hepatology.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28650.
    PubMed     Text format    


  447. MATSUURA K, De Giorgi V, Schechterly C, Wang RY, et al
    Circulating let-7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28660.
    PubMed     Text format     Abstract available


  448. LEE SA, Yuen JJ, Jiang H, Kahn BB, et al
    Adipocyte-specific over-expression of retinol-binding protein 4 (RBP4) causes hepatic steatosis in mice.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28659.
    PubMed     Text format     Abstract available


  449. ZOU Y, Li G, Wang L
    Colony-stimulating factor 1 should be considered when studying the miR-28-5p-IL-34-macrophage feedback loop in hepatocellular carcinoma.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28658.
    PubMed     Text format    


  450. HAPPERTS S, Foucault A, Billiard JS, Nguyen B, et al
    Combined hepatocellular-cholangiocarcinoma in a patient with Abernethy malformation and Tetralogy of Fallot - A case report.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28656.
    PubMed     Text format    


  451. PIANO S, Angeli P
    Terlipressin administration for type 1 hepatorenal syndrome. More answers than open questions.
    Hepatology. 2016 May 17. doi: 10.1002/hep.28648.
    PubMed     Text format    


  452. HEWETT LJ, Bradshaw ML, Gordon LL, Rockey DC, et al
    Diagnosis of isolated hepatic hydrothorax using peritoneal scintigraphy.
    Hepatology. 2016 May 14. doi: 10.1002/hep.28634.
    PubMed     Text format    


  453. SAPISOCHIN G, Goldaracena N, Laurence JM, Dib M, et al
    The extended toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study.
    Hepatology. 2016 May 14. doi: 10.1002/hep.28643.
    PubMed     Text format     Abstract available


  454. WAN ZY, Tian JS, Tan HW, Chow AL, et al
    Mechanistic target of rapamycin complex 1 (mTORC1) is an essential mediator of metabolic and mitogenic effects of FGF19 in hepatoma cells.
    Hepatology. 2016 May 14. doi: 10.1002/hep.28639.
    PubMed     Text format     Abstract available


  455. LI D, Fu J, Du M, Zhang H, et al
    Hepatocellular carcinoma repression by TNFalpha-mediated synergistic lethal effect of mitosis defect-induced senescence and cell death sensitization.
    Hepatology. 2016 May 14. doi: 10.1002/hep.28637.
    PubMed     Text format     Abstract available


  456. LIU M, Chen L, Ma NF, Chow RK, et al
    CHD1L promotes lineage reversion of hepatocellular carcinoma through opening chromatin for key developmental transcription factors.
    Hepatology. 2016;63:1544-1559.
    PubMed     Text format     Abstract available


  457. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:1405-1407.
    PubMed     Text format    


  458. VALANEJAD L, Timchenko N
    Akt-FoxO1 axis controls liver regeneration.
    Hepatology. 2016;63:1424-6.
    PubMed     Text format    


  459. BEZERRA JA
    MDR3 mutation analysis: A step closer to precision medicine.
    Hepatology. 2016;63:1421-3.
    PubMed     Text format    


  460. BLOKS VW, Plosch T, Jonker JW, Kuipers F, et al
    Reply to: "Impaired expression of multidrug resistance-associated protein 2 and liver damage in erythropoietic protoporphyria".
    Hepatology. 2016;63:1743-4.
    PubMed     Text format    


  461. SCHWIMMER JB
    Clinical advances in pediatric nonalcoholic fatty liver disease.
    Hepatology. 2016;63:1718-25.
    PubMed     Text format    


  462. LIASKOU E, Klemsdal Henriksen EK, Holm K, Kaveh F, et al
    High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires.
    Hepatology. 2016;63:1608-19.
    PubMed     Text format     Abstract available


    April 2016
  463. DROLZ A, Horvatits T, Roedl K, Rutter K, et al
    Coagulation parameters and major bleeding in critically ill patients with cirrhosis.
    Hepatology. 2016 Apr 28. doi: 10.1002/hep.28628.
    PubMed     Text format     Abstract available


  464. HSIN IF, Montano E, Seki E
    Finding a new role for NEMO: A key player in preventing hepatocyte apoptosis and liver tumorigenesis by inhibiting RIPK1.
    Hepatology. 2016 Apr 27. doi: 10.1002/hep.28627.
    PubMed     Text format    


  465. TANG H, Bai HX, Su C, Lee AM, et al
    The effect of cirrhosis on radiogenomic biomarker's ability to predict microvascular invasion and outcome in hepatocellular carcinoma.
    Hepatology. 2016 Apr 26. doi: 10.1002/hep.28620.
    PubMed     Text format    


  466. MALIZIA G, Cervello OV, D'Amico G
    Statins in cirrhosis: The magic pill?
    Hepatology. 2016 Apr 26. doi: 10.1002/hep.28616.
    PubMed     Text format    


  467. WU N, Meng F, Invernizzi P, Bernuzzi F, et al
    The secretin/secretin receptor axis modulates liver fibrosis through changes in TGF-beta1 biliary secretion.
    Hepatology. 2016 Apr 26. doi: 10.1002/hep.28622.
    PubMed     Text format     Abstract available


  468. SHIN S, Wangensteen KJ, Teta-Bissett M, Wang YJ, et al
    Genetic Lineage Tracing Analysis of the Cell of Origin of Hepatotoxin-Induced Liver Tumors in Mice.
    Hepatology. 2016 Apr 21. doi: 10.1002/hep.28602.
    PubMed     Text format     Abstract available


  469. CHENG AL, Thongprasert S, Lim HY, Sukeepaisarnjaroen W, et al
    Randomized, Open-Label Phase 2 Study Comparing Frontline Dovitinib vs Sorafenib in Patients With Advanced Hepatocellular Carcinoma.
    Hepatology. 2016 Apr 15. doi: 10.1002/hep.28600.
    PubMed     Text format     Abstract available


  470. GLUUD LL, Vilstrup H, Morgan MY
    Non-Absorbable Disaccharides for Hepatic Encephalopathy: A Systematic Review and Meta-Analysis.
    Hepatology. 2016 Apr 15. doi: 10.1002/hep.28598.
    PubMed     Text format     Abstract available


  471. ARRIVE L, Zucman-Rossi J, Balladur P, Wendum D, et al
    Hepatocellular adenoma with malignant transformation in a patient with neonatal portal vein thrombosis.
    Hepatology. 2016 Apr 4. doi: 10.1002/hep.28590.
    PubMed     Text format    



  472. Correction: Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
    Hepatology. 2016;63:1403.
    PubMed     Text format    


  473. CUBERO FJ
    Shutting off inflammation: A novel switch on hepatic stellate cells.
    Hepatology. 2016;63:1086-9.
    PubMed     Text format    


  474. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:1065-7.
    PubMed     Text format    


  475. MOLLER S
    Toward new standards for noninvasive measuring of portal pressure?
    Hepatology. 2016;63:1384-6.
    PubMed     Text format    


  476. VINCIGUERRA M, Mazzoccoli G
    Aryl hydrocarbon receptor-fibroblast growth factor 21 dissociation of fatty liver from insulin resistance: A timely matter?
    Hepatology. 2016;63:1396-7.
    PubMed     Text format    


  477. LU P, Xie W
    Reply.
    Hepatology. 2016;63:1397-8.
    PubMed     Text format    


  478. STEFANESCU H, Lupsor-Platon M, Badea RI
    The devil's triangle of steatosis, obesity, and liver stiffness.
    Hepatology. 2016;63:1392-3.
    PubMed     Text format    


  479. PETTA S, Craxi A
    Reply.
    Hepatology. 2016;63:1394.
    PubMed     Text format    


  480. TAPPER EB, Lai M
    Weight loss results in significant improvements in quality of life for patients with nonalcoholic fatty liver disease: A prospective cohort study.
    Hepatology. 2016;63:1184-9.
    PubMed     Text format     Abstract available


  481. UNALP-ARIDA A, Ruhl CE
    Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.
    Hepatology. 2016;63:1170-83.
    PubMed     Text format     Abstract available


  482. GUAL P, Postic C
    Therapeutic potential of nicotinamide adenine dinucleotide for nonalcoholic fatty liver disease.
    Hepatology. 2016;63:1074-7.
    PubMed     Text format    


  483. THORGEIRSSON SS
    Stemness and reprogramming in liver cancer.
    Hepatology. 2016;63:1068-70.
    PubMed     Text format    


  484. GARIANI K, Menzies KJ, Ryu D, Wegner CJ, et al
    Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice.
    Hepatology. 2016;63:1190-204.
    PubMed     Text format     Abstract available


  485. SHNEIDER BL, de Ville de Goyet J, Leung DH, Srivastava A, et al
    Primary prophylaxis of variceal bleeding in children and the role of MesoRex Bypass: Summary of the Baveno VI Pediatric Satellite Symposium.
    Hepatology. 2016;63:1368-80.
    PubMed     Text format     Abstract available


  486. PIANO S, Fasolato S, Salinas F, Romano A, et al
    The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial.
    Hepatology. 2016;63:1299-309.
    PubMed     Text format     Abstract available


    March 2016
  487. SERLIE MJ, Ter Horst KW, Brown AW
    Addendum: Hypercaloric diets with high meal frequency, but not increased meal size, increase intrahepatic triglycerides: A randomized controlled trial.
    Hepatology. 2016 Mar 31. doi: 10.1002/hep.28588.
    PubMed     Text format    


  488. KAI AK, Chan LK, Lo RC, Lee JM, et al
    Downregulation of TIMP2 via HIF-1alpha/miR-210/HIF-3alpha regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma.
    Hepatology. 2016 Mar 28. doi: 10.1002/hep.28577.
    PubMed     Text format     Abstract available


  489. KALAMBOKIS GN, Christodoulou D, Baltayiannis G, Christou L, et al
    Propranolol use beyond 6 months increases mortality in patients with Child-Pugh C cirrhosis and ascites.
    Hepatology. 2016 Mar 26. doi: 10.1002/hep.28575.
    PubMed     Text format    


  490. ARAB JP, Shah VH
    Statins and portal hypertension: A tale of two models.
    Hepatology. 2016 Mar 25. doi: 10.1002/hep.28567.
    PubMed     Text format    


  491. REZVANI M, Grimm A, Willenbring H
    Assessing the Therapeutic Potential of Lab-Made Hepatocytes.
    Hepatology. 2016 Mar 25. doi: 10.1002/hep.28569.
    PubMed     Text format     Abstract available


  492. MARRONE J, Soria LR, Danielli M, Lehmann GL, et al
    Hepatic Gene Transfer of Human Aquaporin-1 Improves Bile Salt Secretory Failure in Rats with Estrogen-Induced Cholestasis.
    Hepatology. 2016 Mar 21. doi: 10.1002/hep.28564.
    PubMed     Text format     Abstract available


  493. KANWAL F, Asch SM, Kramer JR, Cao Y, et al
    Early Outpatient Follow-up and 30-day Outcomes in Patients Hospitalized with Cirrhosis.
    Hepatology. 2016 Mar 17. doi: 10.1002/hep.28558.
    PubMed     Text format     Abstract available


  494. RAO Q, Zuo B, Lu Z, Gao X, et al
    Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and human in vitro.
    Hepatology. 2016 Mar 17. doi: 10.1002/hep.28549.
    PubMed     Text format     Abstract available


  495. TAKASHIMA Y, Terada M, Udono M, Miura S, et al
    Suppression of let-7b and miR-125a/b maturation by Lin28b enables maintenance of stem cell properties in hepatoblasts.
    Hepatology. 2016 Mar 17. doi: 10.1002/hep.28548.
    PubMed     Text format     Abstract available


  496. BISSONNETTE J, Garcia-Pagan JC, Albillos A, Turon F, et al
    Role of the Transjugular Intrahepatic Portosystemic Shunt in the Management of Severe Complications of Portal Hypertension in Idiopathic Noncirrhotic Portal Hypertension.
    Hepatology. 2016 Mar 17. doi: 10.1002/hep.28547.
    PubMed     Text format     Abstract available


  497. TREVISANI F, Golfieri R
    Lipiodol transarterial chemoembolization for hepatocellular carcinoma: Where are we now?
    Hepatology. 2016 Mar 16. doi: 10.1002/hep.28554.
    PubMed     Text format    


  498. MCPHAIL MJ, Auzinger G, Bernal W, Wendon JA, et al
    Decisions on futility in patients with cirrhosis and organ failure.
    Hepatology. 2016 Mar 7. doi: 10.1002/hep.28539.
    PubMed     Text format    


  499. GUSTOT T, Fernandez J, Pavesi M, Arroyo V, et al
    Reply to "Decisions on futility in patients with cirrhosis and organ failure".
    Hepatology. 2016 Mar 7. doi: 10.1002/hep.28538.
    PubMed     Text format    


  500. ABRALDES JG, Burak KW
    STAT order: Should patients with chronic liver disease be prescribed statins to prevent fibrosis progression and hepatocellular carcinoma?
    Hepatology. 2016 Mar 4. doi: 10.1002/hep.28537.
    PubMed     Text format    


  501. EL-SERAG HB, Kanwal F, Richardson P, Kramer J, et al
    Risk of Hepatocellular Carcinoma after Sustained Virologic Response in Veterans with HCV-infection.
    Hepatology. 2016 Mar 4. doi: 10.1002/hep.28535.
    PubMed     Text format     Abstract available



  502. Correction: Characterization of the genotype and integration patterns of hepatitis B virus in early- and late-onset hepatocellular carcinoma.
    Hepatology. 2016;63:1064.
    PubMed     Text format    



  503. Correction: Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition via Akt/GSK-3beta/snail signaling.
    Hepatology. 2016;63:1064.
    PubMed     Text format    


  504. SAMARIN J, Laketa V, Malz M, Roessler S, et al
    PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells.
    Hepatology. 2016;63:813-26.
    PubMed     Text format     Abstract available


  505. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:679-81.
    PubMed     Text format    


  506. GUY CD, Diehl AM
    Reply.
    Hepatology. 2016;63:1057-8.
    PubMed     Text format    


  507. ROMAGNOLI R, Mazzaferro V, Bruix J
    Reply.
    Hepatology. 2016;63:1054-5.
    PubMed     Text format    


  508. BOHM M, Vuppalanchi R, Chalasani N
    Febuxostat-induced acute liver injury.
    Hepatology. 2016;63:1047-9.
    PubMed     Text format    


  509. MANN JP, De Vito R, Mosca A, Alisi A, et al
    Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver disease.
    Hepatology. 2016;63:745-53.
    PubMed     Text format     Abstract available


  510. LEE YH, Kim SU, Song K, Park JY, et al
    Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
    Hepatology. 2016;63:776-86.
    PubMed     Text format     Abstract available


  511. DIBRA D, Xia X, Mitra A, Cutrera JJ, et al
    Mutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice.
    Hepatology. 2016;63:1000-12.
    PubMed     Text format     Abstract available


  512. DONATI B, Motta BM, Pingitore P, Meroni M, et al
    The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage.
    Hepatology. 2016;63:787-98.
    PubMed     Text format     Abstract available


  513. BOURSIER J, Mueller O, Barret M, Machado M, et al
    The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.
    Hepatology. 2016;63:764-75.
    PubMed     Text format     Abstract available


  514. BJORNSSON ES, Olafsson JH
    Concomitant drug-induced liver and skin reactions: An Indian experience.
    Hepatology. 2016;63:700-2.
    PubMed     Text format    


  515. SENIOR JR
    Can rechallenge be done safely after mild or moderate drug-induced liver injury?
    Hepatology. 2016;63:691-3.
    PubMed     Text format    


  516. MEHAL WZ
    We are not in Kansas anymore: The unfamiliar landscape of NASH.
    Hepatology. 2016;63:682-4.
    PubMed     Text format    


  517. RINELLA ME
    Screening for nonalcoholic fatty liver disease in patients with atherosclerotic coronary disease?--In principle yes, in practice not yet.
    Hepatology. 2016;63:688-90.
    PubMed     Text format    


  518. DEVARBHAVI H, Raj S, Aradya VH, Rangegowda VT, et al
    Drug-induced liver injury associated with Stevens-Johnson syndrome/toxic epidermal necrolysis: Patient characteristics, causes, and outcome in 36 cases.
    Hepatology. 2016;63:993-9.
    PubMed     Text format     Abstract available


  519. WONG VW, Wong GL, Yeung JC, Fung CY, et al
    Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study.
    Hepatology. 2016;63:754-63.
    PubMed     Text format     Abstract available


  520. BERZIGOTTI A, Saran U, Dufour JF
    Physical activity and liver diseases.
    Hepatology. 2016;63:1026-40.
    PubMed     Text format     Abstract available


    February 2016
  521. YAO L, Wang C, Zhang X, Peng L, et al
    Hyperhomocysteinemia Activates the Aryl Hydrocarbon Receptor-CD36 Pathway to Promote Hepatic Steatosis in Mice.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28518.
    PubMed     Text format     Abstract available


  522. CHEN YY, Jeffery HC, Hunter S, Bhogal R, et al
    Human intrahepatic tregs are functional, require IL-2 from effector cells for survival and are susceptible to fas ligand mediated apoptosis.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28517.
    PubMed     Text format     Abstract available


  523. LEE TH, Rangan V, Khallafi H
    A Case of Sphenoid Sinus Metastasis in Hepatocellular Carcinoma.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28516.
    PubMed     Text format    


  524. GONG Q, Hu Z, Zhang F, Cui A, et al
    Fibroblast Growth Factor 21 Improves Hepatic Insulin Sensitivity by Inhibiting Mammalian Target of Rapamycin Complex 1.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28523.
    PubMed     Text format     Abstract available


  525. DE WAART DR, Naik J, Utsunomiya KS, Duijst S, et al
    ATP11C targets basolateral bile salt transporter proteins in mouse central hepatocytes.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28522.
    PubMed     Text format     Abstract available


  526. TANIMIZU N, Kaneko K, Itoh T, Ichinohe N, et al
    Intrahepatic bile ducts are developed through formation of homogeneous continuous luminal network and its dynamic rearrangement.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28521.
    PubMed     Text format     Abstract available


  527. LIU C, Liu L, Chen X, Cheng J, et al
    Sox9 Regulates Self-Renewal and Tumorigenicity by Promoting Symmetrical Cell Division of Cancer Stem Cells in Hepatocellular Carcinoma.
    Hepatology. 2016 Feb 22. doi: 10.1002/hep.28509.
    PubMed     Text format     Abstract available


  528. LI L, Che L, Tharp KM, Park HM, et al
    Differential Requirement for de novo Lipogenesis in Cholangiocarcinoma and Hepatocellular Carcinoma of Mice and Humans.
    Hepatology. 2016 Feb 22. doi: 10.1002/hep.28508.
    PubMed     Text format     Abstract available


  529. SIMON TG, Bonilla H, Yan P, Chung RT, et al
    Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and HCC, among patients with HCV Results from ERCHIVES.
    Hepatology. 2016 Feb 18. doi: 10.1002/hep.28506.
    PubMed     Text format     Abstract available


  530. D'AMICO G, Malizia G, Bosch J
    Beta-blockers in 2016: Still the safest and most useful drugs for portal hypertension?
    Hepatology. 2016 Feb 18. doi: 10.1002/hep.28502.
    PubMed     Text format    


  531. VILARINHO S, Sari S, Yilmaz G, Stiegler AL, et al
    Recurrent Recessive Mutation in DGUOK Causes Idiopathic Non-Cirrhotic Portal Hypertension.
    Hepatology. 2016 Feb 13. doi: 10.1002/hep.28499.
    PubMed     Text format     Abstract available


  532. CRAIG A, Villanueva A
    Liver Capsule: Molecular-based signatures in hepatocellular carcinoma.
    Hepatology. 2016 Feb 9. doi: 10.1002/hep.28489.
    PubMed     Text format    


  533. WU W, Patel A, Kyostila K, Lohi H, et al
    Genome-wide Association Study in Mice Identifies Loci Affecting Liver-related Phenotypes Including Sel1l Influencing Serum Bile Acids.
    Hepatology. 2016 Feb 9. doi: 10.1002/hep.28495.
    PubMed     Text format     Abstract available


  534. VILAR-GOMEZ E, Yasells-Garcia A, Martinez-Perez Y, Calzadilla-Bertot L, et al
    Development and validation of a noninvasive prediction model for nonalcoholic steatohepatitis resolution after lifestyle intervention.
    Hepatology. 2016 Feb 5. doi: 10.1002/hep.28484.
    PubMed     Text format     Abstract available


  535. OIKAWA T
    Cancer Stem Cells and Their Cellular Origins in Primary Liver and Biliary Tract Cancers.
    Hepatology. 2016 Feb 5. doi: 10.1002/hep.28485.
    PubMed     Text format     Abstract available


  536. TREBICKA J, Schierwagen R
    Hepatic mitochondrial dysfunction in non-alcoholic steatohepatitis: Read-out or reason?
    Hepatology. 2016 Feb 4. doi: 10.1002/hep.28482.
    PubMed     Text format    


  537. TAI WT, Chen YL, Chu PY, Chen LJ, et al
    Protein tyrosine phosphatase 1B dephosphorylates PITX1 and regulates p120RasGAP in hepatocellular carcinoma.
    Hepatology. 2016 Feb 3. doi: 10.1002/hep.28478.
    PubMed     Text format     Abstract available


  538. SAMI S, Mariella C, Valeria DC, Daniele A, et al
    A low-cost, user-friendly EEG recording system for the assessment of hepatic encephalopathy.
    Hepatology. 2016 Feb 2. doi: 10.1002/hep.28477.
    PubMed     Text format     Abstract available


  539. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:351-3.
    PubMed     Text format    


  540. PANG Q, Qu K, Liu C, Zhang JY, et al
    Sarcopenia and nonalcoholic fatty liver disease: New evidence for low vitamin D status contributing to the link.
    Hepatology. 2016;63:675.
    PubMed     Text format    


  541. HONG HC, Choi KM
    Reply.
    Hepatology. 2016;63:675-6.
    PubMed     Text format    


  542. SMAGRIS E, BasuRay S, Gromada J, Cohen JC, et al
    Reply.
    Hepatology. 2016;63:677.
    PubMed     Text format    


  543. ZHAO J, Lawless MW
    Resminostat: Opening the door to epigenetic treatments for liver cancer.
    Hepatology. 2016;63:668-9.
    PubMed     Text format    


  544. CUI J, Heba E, Hernandez C, Haufe W, et al
    Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study.
    Hepatology. 2016;63:453-61.
    PubMed     Text format     Abstract available


  545. HOLSTER IL, Tjwa ET, Moelker A, Wils A, et al
    Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + beta-blocker for prevention of variceal rebleeding.
    Hepatology. 2016;63:581-9.
    PubMed     Text format     Abstract available


  546. BJORNSSON ES, Hoofnagle JH
    Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports.
    Hepatology. 2016;63:590-603.
    PubMed     Text format     Abstract available


  547. REID LM, Sethupathy P
    The DNAJB1-PRKACA chimera: Candidate biomarker and therapeutic target for fibrolamellar carcinomas.
    Hepatology. 2016;63:662-4.
    PubMed     Text format    


    January 2016
  548. TAPPER EB
    Challenge accepted: Confronting readmissions for our patients with cirrhosis.
    Hepatology. 2016 Jan 25. doi: 10.1002/hep.28471.
    PubMed     Text format    


  549. SACK J, Garcia-Tsao G
    Variceal hemorrhage in a patient with HCV cirrhosis in whom liver synthetic function had normalized after viral elimination.
    Hepatology. 2016 Jan 25. doi: 10.1002/hep.28470.
    PubMed     Text format    


  550. KOH MY, Gagea M, Sargis T, Lemos R Jr, et al
    A new HIF-1alpha/RANTES driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF.
    Hepatology. 2016 Jan 22. doi: 10.1002/hep.28468.
    PubMed     Text format     Abstract available


  551. KWO P, Gitlin N, Nahass R, Bernstein D, et al
    Simeprevir Plus Sofosbuvir (12 and 8 Weeks) in HCV Genotype 1-Infected Patients Without Cirrhosis: OPTIMIST-1, a Phase 3, Randomized Study.
    Hepatology. 2016 Jan 22. doi: 10.1002/hep.28467.
    PubMed     Text format     Abstract available


  552. NORONHA FERREIRA C, Seijo S, Plessier A, Silva-Junior G, et al
    Natural history and management of esophagogastric varices in chronic non-cirrhotic non-tumoral portal vein thrombosis.
    Hepatology. 2016 Jan 22. doi: 10.1002/hep.28466.
    PubMed     Text format     Abstract available


  553. CALVISI DF
    Accomplices in Crime: The Diabolical Liaison between PTP1B and Ras in Hepatocellular Carcinoma.
    Hepatology. 2016 Jan 19. doi: 10.1002/hep.28462.
    PubMed     Text format    


  554. LENCIONI R, de Baere T, Soulen MC, Rilling WS, et al
    Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data.
    Hepatology. 2016 Jan 13. doi: 10.1002/hep.28453.
    PubMed     Text format     Abstract available


  555. TADDEI T
    Learning from the Melbourne experience: How reliable are cancer registry data for hepatocellular carcinoma?
    Hepatology. 2016 Jan 13. doi: 10.1002/hep.28452.
    PubMed     Text format    


  556. DESAI SS, Tung JC, Zhou VX, Grenert JP, et al
    Physiological Ranges of Matrix Rigidity Modulate Primary Mouse Hepatocyte Function In Part Through Hepatocyte Nuclear Factor 4 Alpha.
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28450.
    PubMed     Text format     Abstract available


  557. POORDAD F, Schiff ER, Vierling JM, Landis C, et al
    Daclatasvir With Sofosbuvir and Ribavirin for HCV Infection With Advanced Cirrhosis or Post-Liver Transplant Recurrence.
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28446.
    PubMed     Text format     Abstract available


  558. ZHOU SL, Hu ZQ, Zhou ZJ, Dai Z, et al
    miR-28-5p-IL-34-Macrophage Feedback Loop Modulates Hepatocellular Carcinoma Metastasis.
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28445.
    PubMed     Text format     Abstract available


  559. ZHAO L, Wong LL, Shi X, Ji J, et al
    Should hepatic dysplasia nodules and regenerative nodules be regarded as pre-malignant lesions and treated?
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28444.
    PubMed     Text format    


  560. SUNAMI Y, Ringelhan M, Kokai E, Lu M, et al
    Canonical NF-kappaB signaling in hepatocytes acts as a tumor-suppressor in HBV surface antigen-driven HCC by controlling the UPR.
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28435.
    PubMed     Text format     Abstract available



  561. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta-analysis.
    Hepatology. 2016;63:349.
    PubMed     Text format    



  562. Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor-induced epithelial-mesenchymal transition.
    Hepatology. 2016;63:349.
    PubMed     Text format    


  563. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:1-3.
    PubMed     Text format    


  564. LIM KC, Chow PK
    Reply.
    Hepatology. 2016;63:345.
    PubMed     Text format    


  565. DONG C, Peng S
    Contribution of nonignorable environmental factor to impairing liver disease mortality reduction target in China.
    Hepatology. 2016;63:347-8.
    PubMed     Text format    


  566. ZHANG Z, Gao B, Wang FS
    Reply.
    Hepatology. 2016;63:348.
    PubMed     Text format    


  567. GIANNINI EG, Stravitz RT, Caldwell SH
    Portal vein thrombosis and chronic liver disease progression: The closer you look the more you see.
    Hepatology. 2016;63:342-3.
    PubMed     Text format    


  568. DE MATTOS AZ, de Mattos AA
    Model for end-stage liver disease-based allocation system: On the right path, but not there yet.
    Hepatology. 2016;63:344.
    PubMed     Text format    


  569. ROSSO C, Mezzabotta L, Gaggini M, Salomone F, et al
    Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease.
    Hepatology. 2016;63:107-16.
    PubMed     Text format     Abstract available


  570. GOFFREDO M, Caprio S, Feldstein AE, D'Adamo E, et al
    Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study.
    Hepatology. 2016;63:117-25.
    PubMed     Text format     Abstract available


  571. DUFOUR JF
    Time to Abandon NASH?
    Hepatology. 2016;63:9-10.
    PubMed     Text format    


  572. KOEHLER EM, Plompen EP, Schouten JN, Hansen BE, et al
    Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study.
    Hepatology. 2016;63:138-47.
    PubMed     Text format     Abstract available


    December 2015
  573. WANG PX, Zhang XJ, Li H
    IRFs in hepatocytes pathophysiology.
    Hepatology. 2015 Dec 28. doi: 10.1002/hep.28433.
    PubMed     Text format    


  574. OH Y, Park O, Swierczewska M, Hamilton JP, et al
    Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells.
    Hepatology. 2015 Dec 28. doi: 10.1002/hep.28432.
    PubMed     Text format     Abstract available


  575. INTAGLIATA NM, Caldwell SH, Porte RJ, Lisman T, et al
    Prediction of bleeding in cirrhosis patients: Is the forecast any clearer?
    Hepatology. 2015 Dec 24. doi: 10.1002/hep.28426.
    PubMed     Text format    


  576. LAWITZ E, Matusow G, DeJesus E, Yoshida EM, et al
    Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A Phase 3 study (OPTIMIST-2).
    Hepatology. 2015 Dec 24. doi: 10.1002/hep.28422.
    PubMed     Text format     Abstract available


  577. TANOUE S, Kaplan DE
    CD14 regulatory Dendritic Cells in Hepatocellular Carcinoma and Cirrhotic patients.
    Hepatology. 2015 Dec 24. doi: 10.1002/hep.28419.
    PubMed     Text format    


  578. MAZZAFERRO V
    Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach.
    Hepatology. 2015 Dec 24. doi: 10.1002/hep.28420.
    PubMed     Text format    


  579. XIAO S, Chang RM, Yang MY, Lei X, et al
    ACTL6A predicts poor prognosis of Hepatocellular carcinoma and promotes metastasis and Epithelial-mesenchymal transition.
    Hepatology. 2015 Dec 23. doi: 10.1002/hep.28417.
    PubMed     Text format     Abstract available


  580. WANG MD, Wu H, Fu GB, Zhang HL, et al
    Acetyl-CoA carboxylase alpha promotion of glucose-mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients.
    Hepatology. 2015 Dec 23. doi: 10.1002/hep.28415.
    PubMed     Text format     Abstract available


  581. BAJAJ JS, Reddy KR, Tandon P, Wong F, et al
    The Three-Month Readmission Rate Remains Unacceptably High in a Large North American Cohort of Cirrhotic Patients.
    Hepatology. 2015 Dec 21. doi: 10.1002/hep.28414.
    PubMed     Text format     Abstract available


  582. IWAGAMI Y, Huang CK, Olsen MJ, Thomas JM, et al
    Aspartate beta-hydroxylase modulates cellular senescence via glycogen synthase kinase 3beta in hepatocellular carcinoma.
    Hepatology. 2015 Dec 19. doi: 10.1002/hep.28411.
    PubMed     Text format     Abstract available


  583. FURUTA K, Yoshida Y, Ogura S, Kurahashi T, et al
    Gab1 adaptor protein acts as a gatekeeper to balance hepatocyte death and proliferation during acetaminophen-induced liver injury in mice.
    Hepatology. 2015 Dec 17. doi: 10.1002/hep.28410.
    PubMed     Text format     Abstract available


  584. GUO Y, Wang J, Zhang L, Shen S, et al
    Theranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma.
    Hepatology. 2015 Dec 17. doi: 10.1002/hep.28409.
    PubMed     Text format     Abstract available


  585. MEHTA N, Yao FY
    Nucleos(t)ide analogues to reduce the risk of Hepatitis B associated hepatocellular carcinoma: A can't miss proposition?
    Hepatology. 2015 Dec 17. doi: 10.1002/hep.28404.
    PubMed     Text format    


  586. ZHOU CC, Yang F, Yuan SX, Ma JZ, et al
    Systemic genome screening identified the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinoma.
    Hepatology. 2015 Dec 13. doi: 10.1002/hep.28393.
    PubMed     Text format     Abstract available


  587. OUYANG HY, Xu J, Luo J, Zou RH, et al
    MEP1A contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinoma.
    Hepatology. 2015 Dec 13. doi: 10.1002/hep.28397.
    PubMed     Text format     Abstract available


  588. CAVALLIN M, Piano S, Romano A, Fasolato S, et al
    Terlipressin given by continuous i.v. infusion versus i.v. boluses in the treatment of hepatorenal syndrome: A randomized controlled study.
    Hepatology. 2015 Dec 13. doi: 10.1002/hep.28396.
    PubMed     Text format     Abstract available


  589. ZHANG Y, Liu Y, Duan J, Yan H, et al
    Hippocalcin-like 1 suppresses hepatocellular carcinoma progression by promoting p21 stabilization via activating ERK1/2-MAPK pathway.
    Hepatology. 2015 Dec 13. doi: 10.1002/hep.28395.
    PubMed     Text format     Abstract available


  590. LAN X, Yan J, Ren J, Zhong B, et al
    A Novel Long Non-coding RNA Lnc-HC Binds hnRNPA2B1 to Regulate Expressions of Cyp7a1 and Abca1 in Hepatocytic Cholesterol Metabolism.
    Hepatology. 2015 Dec 11. doi: 10.1002/hep.28391.
    PubMed     Text format     Abstract available


  591. TOSELLO-TRAMPONT AC, Krueger P, Narayanan S, Landes SG, et al
    NKp46 NK cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation.
    Hepatology. 2015 Dec 10. doi: 10.1002/hep.28389.
    PubMed     Text format     Abstract available


  592. CHEN DS, Liaw YF, Chen CJ, Wu JC, et al
    Differences in hepatitis viral etiology of hepatocellular carcinoma in Taiwan and China.
    Hepatology. 2015 Dec 10. doi: 10.1002/hep.28378.
    PubMed     Text format    


  593. LOCATELLI L, Cadamuro M, Spirli C, Fiorotto R, et al
    Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis.
    Hepatology. 2015 Dec 8. doi: 10.1002/hep.28382.
    PubMed     Text format     Abstract available


  594. SEKI E
    HEDGEHOG signal in Hepatocytes mediates Macrophage Recruitment: A New Mechanism and Potential Therapeutic Target for Fatty Liver Disease.
    Hepatology. 2015 Dec 5. doi: 10.1002/hep.28381.
    PubMed     Text format    


  595. CHO NE, Bang BR, Gurung P, Li M, et al
    Retinoid Regulation of Antiviral Innate Immunity in Hepatocytes.
    Hepatology. 2015 Dec 5. doi: 10.1002/hep.28380.
    PubMed     Text format     Abstract available


  596. EKSTEEN B
    Predicting risk in Primary Biliary Cholangitis.
    Hepatology. 2015 Dec 5. doi: 10.1002/hep.28377.
    PubMed     Text format    



  597. 2015 Hepatology referees (volumes 61 and 62).
    Hepatology. 2015;62:1926-1930.
    PubMed     Text format    


  598. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2015;62:1649-1651.
    PubMed     Text format    


    November 2015
  599. GUO H, Jing L, Cheng Y, Atsaves V, et al
    Downregulation of the Cyclin-Dependent Kinase Inhibitor p57 Is Mediated by Jab1/Csn5 in Hepatocarcinogenesis.
    Hepatology. 2015 Nov 25. doi: 10.1002/hep.28372.
    PubMed     Text format     Abstract available


  600. BLASI A, Hernandez-Gea V, Reverter JC, Garcia-Pagan JC, et al
    Quality of anticoagulation and outcome of bleeding in cirrhosis.
    Hepatology. 2015 Nov 25. doi: 10.1002/hep.28371.
    PubMed     Text format    


  601. QI X, De Stefano V, Guo X
    Quality of anticoagulation and outcome of bleeding in cirrhosis.
    Hepatology. 2015 Nov 25. doi: 10.1002/hep.28369.
    PubMed     Text format    


  602. BOSSEN L, Krag A, Vilstrup H, Watson H, et al
    Non-selective beta-blockers do not affect mortality in cirrhosis patients with ascites: Post hoc analysis of three RCTs with 1198 patients.
    Hepatology. 2015 Nov 24. doi: 10.1002/hep.28352.
    PubMed     Text format     Abstract available


  603. PISCAGLIA F, Svegliati-Baroni G, Barchetti A, Pecorelli A, et al
    Clinical patterns of hepatocellular carcinoma (hcc) in non alcoholic fatty liver disease (NAFLD): A multicenter prospective study.
    Hepatology. 2015 Nov 24. doi: 10.1002/hep.28368.
    PubMed     Text format     Abstract available


  604. JUNG KH, Zhang J, Zhou C, Shen H, et al
    Differentiation therapy for hepatocellular carcinoma: Multifaceted effects of miR-148a on tumor growth and phenotype and liver fibrosis.
    Hepatology. 2015 Nov 24. doi: 10.1002/hep.28367.
    PubMed     Text format     Abstract available


  605. REYES H
    Sulfated progesterone metabolites in the pathogenesis of intrahepatic cholestasis of pregnancy: Another loop in the ascending spiral of medical knowledge.
    Hepatology. 2015 Nov 24. doi: 10.1002/hep.28365.
    PubMed     Text format    


  606. FERRER-FABREGA J, Forner A, Liccioni A, Miquel R, et al
    Prospective validation of "ab initio" liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection.
    Hepatology. 2015 Nov 13. doi: 10.1002/hep.28339.
    PubMed     Text format     Abstract available


  607. GALUN E
    Liver inflammation and cancer: The role of tissue microenvironment in generating the tumor-promoting niche (TPN) in the development of hepatocellular carcinoma.
    Hepatology. 2015 Nov 13. doi: 10.1002/hep.28344.
    PubMed     Text format    


  608. DOSHI M, Pereira K, Carrion A, Martin P, et al
    Antegrade embolization of spontaneous splenorenal shunt for Post-TIPS refractory Hepatic Encephalopathy.
    Hepatology. 2015 Nov 13. doi: 10.1002/hep.28343.
    PubMed     Text format    


  609. FERNANDEZ J, Tandon P, Mensa J, Garcia-Tsao G, et al
    Antibiotic prophylaxis in cirrhosis: Good and bad.
    Hepatology. 2015 Nov 3. doi: 10.1002/hep.28330.
    PubMed     Text format     Abstract available


  610. JAESCHKE H, Du K
    Benzyl Alcohol: A novel treatment for acetaminophen overdose?
    Hepatology. 2015;62:1641-2.
    PubMed     Text format    


  611. ZUCKERBRAUN BS, Cai C, Billiar TR
    Reply: To PMID 24798499.
    Hepatology. 2015;62:1642.
    PubMed     Text format    


  612. YANG T, Zhang H, Lau WY, Shen F, et al
    Liver disease in China: A long way to go.
    Hepatology. 2015;62:1640.
    PubMed     Text format    


  613. ZHANG Z, Fan JG, Wang FS
    Reply: To PMID 25164003.
    Hepatology. 2015;62:1640-1.
    PubMed     Text format    


  614. BLECHACZ B, Mishra L
    Biopsy for liver cancer: How to balance research needs with evidence-based clinical practice.
    Hepatology. 2015;62:1645.
    PubMed     Text format    


  615. LEUNG DH, Khan M, Minard CG, Guffey D, et al
    Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease.
    Hepatology. 2015;62:1576-83.
    PubMed     Text format     Abstract available


  616. SIDDIQUE HR, Feldman DE, Chen CL, Punj V, et al
    NUMB phosphorylation destabilizes p53 and promotes self-renewal of tumor-initiating cells by a NANOG-dependent mechanism in liver cancer.
    Hepatology. 2015;62:1466-79.
    PubMed     Text format     Abstract available


  617. JO YS, Ryu D, Maida A, Wang X, et al
    Phosphorylation of the nuclear receptor corepressor 1 by protein kinase B switches its corepressor targets in the liver in mice.
    Hepatology. 2015;62:1606-18.
    PubMed     Text format     Abstract available


  618. HAGIWARA S, Nishida N, Park AM, Sakurai T, et al
    Impaired expression of ATP-binding cassette transporter G2 and liver damage in erythropoietic protoporphyria.
    Hepatology. 2015;62:1638-9.
    PubMed     Text format    


    October 2015
  619. YOKOMORI H, Yamazaki H, Oda M
    Freshwater clam extract supplement induced acute cholestasis.
    Hepatology. 2015 Oct 30. doi: 10.1002/hep.28320.
    PubMed     Text format    


  620. STINDT J, Kluge S, Droge C, Keitel V, et al
    Bile Salt Export Pump-reactive Antibodies Form a Polyclonal, Multi-inhibitory Response in Antibody-induced BSEP Deficiency.
    Hepatology. 2015 Oct 30. doi: 10.1002/hep.28311.
    PubMed     Text format     Abstract available


  621. HALAZUN KJ, Patzer RE, Rana AA, Samstein B, et al
    Reply: To PMID 24954365.
    Hepatology. 2015;62:1328-9.
    PubMed     Text format    


  622. YANG T, Lau WY, Huang B, Schwartz M, et al
    Transplantation for hepatocellular carcinoma: more haste, less speed?
    Hepatology. 2015;62:1327-8.
    PubMed     Text format    


  623. CLOSS EI
    Putative role of cationic amino acid transporter-3 in murine liver metabolism.
    Hepatology. 2015;62:1326-7.
    PubMed     Text format    


  624. GU Q, Cui Z
    Reply: To PMID 25130427.
    Hepatology. 2015;62:1327.
    PubMed     Text format    


  625. DALY AK, Day CP, Liu YL, Anstee QM, et al
    TM6SF2 as a genetic risk factor for fibrosis.
    Hepatology. 2015;62:1321.
    PubMed     Text format    


  626. SOOKOIAN S, Pirola CJ
    Reply: To PMID 25302781.
    Hepatology. 2015;62:1321-2.
    PubMed     Text format    


  627. VERMA M, Navarro V
    Patient-centered care: a new paradigm for chronic liver disease.
    Hepatology. 2015;62:988-90.
    PubMed     Text format    


  628. LEE YK, Jee BA, Kwon SM, Yoon YS, et al
    Identification of a mitochondrial defect gene signature reveals NUPR1 as a key regulator of liver cancer progression.
    Hepatology. 2015;62:1174-89.
    PubMed     Text format     Abstract available


  629. TOROK NJ
    Vascular adhesion protein 1 in nonalcoholic steatohepatitis: a novel biomarker?
    Hepatology. 2015;62:1313-5.
    PubMed     Text format    


  630. GUO W, Qiu Z, Wang Z, Wang Q, et al
    MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer.
    Hepatology. 2015;62:1132-44.
    PubMed     Text format     Abstract available


  631. CHANG B, Xu MJ, Zhou Z, Cai Y, et al
    Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1.
    Hepatology. 2015;62:1070-85.
    PubMed     Text format     Abstract available


  632. PETTA S, Maida M, Macaluso FS, Di Marco V, et al
    The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease.
    Hepatology. 2015;62:1101-10.
    PubMed     Text format     Abstract available


  633. LAI M
    Is liver stiffness measurement to stage fibrosis in patients with nonalcoholic fatty liver disease ready for clinical use?
    Hepatology. 2015;62:997-8.
    PubMed     Text format    


    September 2015
  634. ZHOU M, Marc Learned R, Rossi SJ, DePaoli AM, et al
    Engineered FGF19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice.
    Hepatology. 2015 Sep 29. doi: 10.1002/hep.28257.
    PubMed     Text format     Abstract available


  635. PONSIOEN CY, Chapman RW, Chazouilleres O, Hirschfield GM, et al
    Surrogate endpoints for clinical trials in primary sclerosing cholangitis; review and results from an International PSC Study Group consensus process.
    Hepatology. 2015 Sep 29. doi: 10.1002/hep.28256.
    PubMed     Text format     Abstract available


  636. KIM SH, Saide K, Farrell J, Faulkner L, et al
    Characterization of amoxicillin- and clavulanic acid-specific T cells in patients with amoxicillin-clavulanate-induced liver injury.
    Hepatology. 2015;62:887-99.
    PubMed     Text format     Abstract available


  637. ZHOU JN, Zeng Q, Wang HY, Zhang B, et al
    MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
    Hepatology. 2015;62:801-15.
    PubMed     Text format     Abstract available


  638. REIG M, Bruix J
    Pattern of tumor progression in liver cancer: The missing partner in trial design.
    Hepatology. 2015;62:674-6.
    PubMed     Text format    


  639. VANWAGNER LB, Wilcox JE, Colangelo LA, Lloyd-Jones DM, et al
    Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study.
    Hepatology. 2015;62:773-83.
    PubMed     Text format     Abstract available


  640. BUTLER NS, Schmidt NW
    Erythropoietin-producing hepatocellular receptor B2 receptor tyrosine kinase: A novel regulator of infection- and inflammation-induced liver fibrosis.
    Hepatology. 2015;62:680-3.
    PubMed     Text format    


  641. NAULT JC, Rebouissou S, Zucman Rossi J
    NRF2/KEAP1 and Wnt/beta-catenin in the multistep process of liver carcinogenesis in humans and rats.
    Hepatology. 2015;62:677-9.
    PubMed     Text format    


  642. HOKI T, Miyanishi K, Tanaka S, Takada K, et al
    Increased duodenal iron absorption through up-regulation of divalent metal transporter 1 from enhancement of iron regulatory protein 1 activity in patients with nonalcoholic steatohepatitis.
    Hepatology. 2015;62:751-61.
    PubMed     Text format     Abstract available


  643. MARZANO C, Cazals-Hatem D, Rautou PE, Valla DC, et al
    The significance of nonobstructive sinusoidal dilatation of the liver: Impaired portal perfusion or inflammatory reaction syndrome.
    Hepatology. 2015;62:956-63.
    PubMed     Text format     Abstract available


    August 2015
  644. TRIVEDI PJ, Corpechot C, Pares A, Hirschfield GM, et al
    Risk Stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists.
    Hepatology. 2015 Aug 20. doi: 10.1002/hep.28128.
    PubMed     Text format     Abstract available


    June 2015
  645. CHIANG JY
    Negative feedback regulation of bile acid metabolism: impact on liver metabolism and diseases.
    Hepatology. 2015 Jun 29. doi: 10.1002/hep.27964.
    PubMed     Text format    


  646. CARULLI L, Gabbi C, Bertolotti M
    Bile acids and non-alcoholic fatty liver disease: An intriguing relationship.
    Hepatology. 2015 Jun 29. doi: 10.1002/hep.27963.
    PubMed     Text format    


  647. BARBIER-TORRES L, Beraza N, Fernandez-Tussy P, Lopitz-Otsoa F, et al
    Histone Deacetylase 4 promotes cholestatic liver injury in the absence of Prohibitin-1.
    Hepatology. 2015 Jun 25. doi: 10.1002/hep.27959.
    PubMed     Text format     Abstract available


    May 2015
  648. KUMAR S
    Cholestatic Liver Injury secondary to Artemisinin.
    Hepatology. 2015 May 16. doi: 10.1002/hep.27900.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: